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There is limited research on hearing loss in the paediatric population infected with HIV/AIDS 
in South Africa. There is a need to establish an audiological profile in HIV infected children, 
as the prevalence of hearing loss is not known and there is limited published research 
available. This information will assist the audiologist to ascertain the extent of the disorder, 
establish a profile of hearing loss using hearing loss type, degree, configuration and 
symmetry, and dictate the necessary audiological and medical management strategies 
required. The aim of the study was to determine the audiological profile of school age 
children with HIV/AIDS at an antiretroviral clinic in KwaZulu-Natal. The study had the 
following objectives:  To describe the prevalence and nature of hearing loss in terms of 
degree, type, configuration and symetry. To determine whether children with a hearing loss 
have received medical management and the type of treatment receive and to determine 
whether children with a hearing loss have received audiological management for their hearing 
loss and the nature of these interventions. 
 
This was achieved through a non-experimental descriptive exploratory design. The research 
was carried out at the Philani Family Clinic which is an ARV clinic at King Edward VIII 
hospital in KwaZulu-Natal, South Africa. Convenience sampling was used to recruit 30 
participants aged between 6-12 years. Seventeen (60%) participants were males and 13 (40%) 
were females. The participants underwent diagnostic audiological evaluation, which included 
a case history questionnaire, medical record review, otoscopic examination, immittance 
audiometry, pure tone audiometry, speech audiometry, Distortion Product Otoacoustic 




The results revealed, abnormal otoscopic findings in the right ear of 17 (57%) participants 
and the left ear of 19 (63%) participants. Tympanometry results revealed abnormal 
tympanograms in the right ear of 13 (43%) participants and the left ear of 12 (40%) 
participants. Ipsilateral acoustic reflex thresholds were abnormal in the right ear of 8 (27%) 
participants and in the left ear of 7 (24%) participants. Contra lateral acoustic reflex 
thresholds were abnormal in the right ear of 13 (44%) participants and in the left ear of 12 
(40%) participants.  Of the 28 participants assessed for pure tone audiometry, 15 (54%) 
presented with normal hearing in the right ear and 13 (46%) presented with normal hearing in 
the left ear. Conductive hearing loss was the most prevalent type of hearing loss, followed by 
sensorineural hearing loss and mixed hearing loss. Good SRT-PTA correlation was obtained 
in majority of the participants, indicating good test reliability. Only 18 participants underwent 
DPOAE testing and pass results were obtained in the right ear of 15 (50%) participants and 
the left ear of 12 (40%) participants.  The ABR results revealed auditory dysfunction 
suggestive of neural dysnchrony. 
Seventeen (43%) participants reported a history of ear infections with 15 (50%) participants 
reporting having receiving medical attention for ear infections. Three (10%) participants were 
fitted with hearing aids. Fourteen (46%) participants reported to have repeated a school 
grade. Fifteen (50%) participants reported not coping academically. 
 
Study limitations included time constraints to conduct a more in depth protocol.  A small 
sample size limited generalisation to the entire population under study. The study concluded 
that there was  a prevalence of 53% hearing loss among children with HIV/AIDS. Therefore, 
the prevalence of hearing loss requires the expertise of the audiologist in the multi-
disciplinary team, to both monitor and manage hearing loss and thereby  improve quality of 
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life of children with compromised immune systems  . “It is always seems impossible until it is 
done” Nelson Mandela 
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CHAPTER 1:  INTRODUCTION 
 
1.1. Introduction  
This chapter introduces the rationale of the study, the research question, and key concepts 
used in the study. The chapter highlights the study aim and objectives. It also provides a short 
summary of forthcoming chapters.  
 
1.2. Background 
Acquired Immunodeficiency Syndrome (AIDS) develops as a result of the Human 
Immunodeficiency Virus (HIV) (Bankaitis & Schountz, 1998). It is a disorder characterised 
by the inability of the human body to defend itself against opportunistic infections. The 
disease is known to progress in stages, namely; the early, intermediate and final stages 
(Matas, Leite, Leite-Magliaro & Gonvcalves, 2006; Friedman & Noffsinger 1998). The 
disease progression has been linked to the maturity level of the immune system. Children are 
believed to be more susceptible to infection due to their immune functioning differing from 
adults and their immune systems being under developed (Bankaitis, Christensen, Murphy & 
Morehouse, 1998). It is estimated by Human Resource Council of South Africa (2014) that 
the number of children infected with HIV is approximately 360 000 or 2.4% in South Africa. 
Sub-Saharan Africa has highest number of children under the age of  13 years living with 
HIV/AIDS (Human research council, 2014). HIV/AIDS is known to result in sequale that 
affect the different organs of the body including the auditory system (Govender, Eley, 




One of the many sequale associated with HIV/AIDS is hearing impairment (Bankaitis & 
Schountz, 1998), with the predominant cause being strongly attributed to otologic infections 
(Gurney & Murr, 2003). Otologic conditions may give rise to a conductive, mixed, or 
sensorineural hearing loss, as well as central auditory deficits (Abrams, Moon, Robinson & 
van Dyke, 2006). Conductive hearing loss in the HIV/AIDS infected population may be as a 
result of otitis media, mastoiditis, tympanic membrane perforation, and recurrent otitis media 
with effusion (Abrams et al., 2006). Viral or bacterial infections, such as Cryptococcus 
meningitis, toxoplasmosis, viral meningitis, cytomegalovirus (CMV) and herpes can result in 
a sensorineural hearing loss. Neurological and central nervous system (CNS) abnormalities 
such as enchaphalopathy with associated language delays, and motor deficits have been 
reported in children with HIV/AIDS (Epstein, Sharer, Oleske, Connor, Goudsmith et al., 
1986). One can therefore, conclude that a hearing loss which is conductive or sensorineural in 
nature could be as a result of otologic and/or central pathology, which may present in varying 
degrees of hearing loss. 
 
Reports indicate varying types, degrees and configurations of hearing loss (Simdon, Watters, 
Bartlett & Connick, 2001), with the reported incidence of hearing impairment in children 
with HIV/AIDS varying from approximately 20% to 40%  internationally (Matas, dos Santos  
Filho, de Juan, Pinto & Gonclaves, 2010). Two point four percent of the HIV/AIDS 
paediatric population in South Africa consist of primary school age children (6-12 years) and 
their hearing status is unknown as there is no data reporting on the number of children 
presenting with hearing loss (Smith, Adamns & Eley, 2008; South African Statistics, 2010 & 
National Department of Health, 2011). Olusanya, Okolo and Ijaduola (2000) estimated that 
50% of school entrance grade children in Nigeria presented with a hearing loss that was not 
reported by the parents or detected through a universal hearing screening program, while 
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North-Matthiassen and Singh (2006) reported that 13,5% of children screened in the  Western 
Cape required referrals for diagnostic audiological evaluation. North-Matthiassen and Singh 
(2006) reported that some of the contributing factors to the high prevalence of hearing loss in 
school children could be attributed to HIV positive children surviving longer due to 
antiretroviral treatment. Due to the life prolonging antiretroviral treatment, one can assume 
that hearing loss prevalence in school age children will be higher (North-Matthiassen & 
Singh, 2006). However, there is scarcity of data that directly links hearing loss to HIV/AIDS 
in adults, and one can conclude that the scarcity of data will be more so in the paediatric 
population (Khoza-Shangase, 2010).   
 
Hearing loss, irrespective of the type, has adverse effects on  linguistic development in 
children (Cook, Kirk, Bidwel, Hider & Tolan, 1998). There are adverse effects of hearing 
loss on speech perception, self-image and social skills  (Niskar et al., 1998). Hearing loss can 
have a negative impact on early language development, affecting the different components of 
language such as syntax, semantics and other basic verbal skills (Feagans, Kipp & Blood, 
1994). Zumach, Gerrits, Chenault, and Anteunis (2010) reported that language development 
is critical during the early childhood years, as it is essential for thinking and learning. Hence, 
hearing loss in the early years of life may result in gaps in the acquisition of language and 
learning affecting the school age population (Feagans et al., 1994; Niskar et al., 1998).  It can 
also adversely impact the classroom and listening environments, as auditory dysfunction 
affects perception and understanding of speech sounds (Niskar et al., 1998).  In addition, 
early onset of any hearing loss could result in reduced processing at the lower brainstem and 
cortical levels in subsequent years. This suggests that early onset of a hearing loss may lead 
to auditory processing difficulties (Maruthy & Mannarukrishnaiah, 2008), making it 




To ensure that all children, including those with HIV related hearing loss, be given a fair and 
equal opportunity to achieve academically, hearing loss must be identified early and managed 
so that it does not negatively impede their ability to lead independent lives (Broste, Hansen, 
Strand & Steuland, 1989). Early diagnosis is crucial in school age children, and one can 
assume that those infected with HIV, as they are prone to hearing loss (Broste et al., 1989). 
The audiologist must, therefore, be involved in the early management of school-age children 
infected with HIV to minimise adverse effects of hearing loss on academic performance and 
their general quality of life.  
 
1.3. Problem statement  
There is limited research on the occurrence and nature of hearing loss in the paediatric 
population infected with HIV/AIDS in South Africa as majority of published research 
relating to HIV/AIDS and hearing research is focused on the adult population (Khoza-
Shangase, 2010, North-Matthiasen & Singh, 2006). One can conclude that there is  need to 
establish an audiological profile of HIV infected children, as the prevalence of hearing loss is 
not known. There is no published research available on the audiological profile of school age 
children infected with HIV/AIDS at antiretroviral clinics in KwaZulu-Natal, and the type of 
audiological and medical management they receive. This information will assist the 
audiologist to ascertain the extent of the disorder, establish a profile of hearing loss using 
hearing loss type, degree, configuration and symmetry, and influence the appropriate 
audiological and medical management strategies required. The role of the audiologist in the 
multidisciplinary management of HIV infected children is important and necessary (Matas et 
al., 2010). Services such as audiological screening, periodical monitoring and aural 
rehabilitation service which involve the audiologist in the management team for children 
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living with HIV is needed to minimise the impact on hearing, communication, academic 
performance and vocational opportunities (Copley & Frederichs, 2010). 
 
1.4. Research Question 
What is the audiological profile of school age children with HIV/AIDS at an antiretroviral 
clinic in KwaZulu-Natal, and what type of audiological and medical management do they 
receive, if any? 
 
1.5. Significance of the study  
The findings of the current study will add to the existing knowledge relating to HIV/AIDS 
and hearing in children. In addition it will be one of the few studies that is specifically 
focused on the paediatric school age population in the South African context, as majority of 
published research relating to HIV/AIDS and hearing research is focused on the adult 
population.  Currently the South African government has invested millions of Rands into 
improving access to ARV and the public health system (National Department of Health, 
2011). Children with HIV/AIDS have historically been referred for audiological assessment 
and intervention when otologic conditions have manifested not for preventative screening. 
This research will highlight the integral aspect of the audiological services as part of the ARV 
service package to improve service delivery. 
 
1.6. Terminology and Abbreviations 
The following section will provide definitions and brief descriptions of terms that will be 
used in the study: 
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 Acoustic Reflexes Thresholds (ARTs) test: This test is used to ascertain the minimal 
level of sound that triggers a reflex via the stapedius muscle of the middle ear (Hall & 
Swanepoel, 2011). 
 Acquired Immunodeficiency Syndrome (AIDS): is a disorder characterised by the 
immune system’s inability to defend the body against various infectious agents as a 
result of HIV (Gold & Tami, 1998). 
 Antiretroviral drug: counters or acts against a retrovirus, understood to be HIV. The 
FDA-approved antiretroviral include reverse transcriptase inhibitors, nucleoside 
analogues and protease inhibitors (Hughes, 1995). 
 Auditory Brainstem Response (ABR) test:  is a neurological test of auditory brainstem 
function in response to auditory (click) stimuli (Janssen, 2008). Although the ABR 
provides information regarding auditory function and hearing sensitivity, it is not a 
substitute for a formal hearing evaluation and results should be used in conjunction 
with behavioural audiometry (American Academy of Audiology, 2002). ABR may be 
useful in monitoring subtle neurological changes (Norrix, Trempanier, Atlas, & Kim 
2012). 
 Cluster Difference Cell 4 (CD4): a major classification of T lymphocytes, referring to 
those that carry the CD4 antigen; most are helper cells. Also called CD4 T 
lymphocytes (Graber et al., 2008). 
 Highly Active Antiretroviral Therapy (HAART): is the name given to aggressive 
treatment regimens used to suppress HIV viral replication and the progression of HIV 




 Human Immunodeficiency Virus (HIV): causes acquired immune deficiency 
syndrome (AIDS).  It replicates in and kills the helper T cells (Gross, Wolff, Elidan & 
Elishar 2007). 
  Opportunistic infections: are secondary infections that occur in patients whose 
immune systems are compromised, such as in AIDS (Gurney & Murr, 2003). 
 Otoacoustic Emissions (OAE): The primary purpose of OAE testing is to determine 
cochlear status, specifically hair cell function with different type of stimuli such as 
transient evoked emissions (TEOAE), distortion product emissions (DPOAE) and 
spontaneous emissions (SOAE) (Delehaye et al., 2008).  
 Otologic diseases: are pathologies related to the structure of the ear (Chandrasekhar, 
et al., 2000). 
 Otoscopy: This test is done to identify pathological conditions of the pinna, ear canal, 
tympanic membrane (eardrums) and surrounding structures (Gelfand, 2001). 
 Pure tones: The purpose of this test is to establish the client’s hearing sensitivity 
across the range of audible frequencies that are vital for human communication. It is 
used to identify hearing threshold levels of an individual, enabling determination of 
the degree, type and configuration of a hearing loss, thus providing the basis for 
diagnosis and type of management strategy required (Arlinger, 2000). 
 Retrovirus: is a group of viruses that contain two single-strand linear RNA molecules 
per virion and reverse transcriptase (RNA to DNA); the virus transcribes its RNA into 
a cDNA provirus that is then incorporated into the host cell (Meuller & Pizzo, 1997). 
There are two variants of the HIV virus, HIV-1 and HIV-2, both of which ultimately 
cause AIDS (Krogstad, 2006; Lindegren, Hammett, & Butleys, 2006). 
 Speech Audiometry: Can be divided into Speech reception testing (SRT) and Speech 
Discrimination testing (SDT).  
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 Speech Discrimination testing (SDT) testing: determines the level of discrimination 
ability between sounds.  The discrimination score is intended to be a measure of the 
clarity of which the person hears speech as well assisting in the detection of acoustic 
tumors and determining the individual’s candidacy for hearing aids (Hall & 
Swanepoel, 2010). 
 Speech Reception Thresholds (SRT): is defined as the level at which the listener can 
identify speech signal 50% of the time.  It is a reliability test for pure tones and 
confirms the results of pure tone audiometry Gelfand, 2001). 
 Tympanometry: Tympanometry is an objective test used to assess the condition of the 
middle ear and mobility of the eardrum (tympanic membrane) and the conduction 
bones by creating variations of air pressure in the ear canal (Beigh, Malik, Islam, 
Yousuf & Pampari, 2012). 
 
1.7.  Outline of the chapters 
 
  Chapter 1. Introduction:  
In this chapter the researcher will introduce the rationale of the study, highlights the 
research question, key concepts used in the study and significance of the study. Finally 
the study aims, and objectives will be introduced with a brief outline of the chapter 
provided. 
 
 Chapter 2. Literature Review:  
This chapter focuses on the epidemiology, classification system of HIV, the impact of the 
virus on the auditory and vestibular system. The impact of hearing loss on language 
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development, academic performance and the role of the audiologist in the management of 
paediatric population infected with HIV/AIDS are discussed. 
 
 Chapter 3. Methodology:  
This chapter outlines the methodological framework of the study, and includes the aims, 
objectives, study design, sample size, as well as the criteria used for the participant 
selection. In addition, there is a description of the investigative procedures used, data 
collection tools and data analysis. 
 
 Chapter 4. Results:  
This chapter presents the results of the study. The use of figures and tables serves to 
enhance the presentation and make clear the findings of the study. 
 
 Chapter 5. Discussion:  
This chapter focuses on the discussion of the findings of the study, while making 
reference to available literature. A discussion will be made regarding the current research 
findings and report on the similarities and differences to other related research in the 
context of paediatric HIV/AIDS. 
 
 Chapter 6. Conclusion:  
Chapter 6 is the conclusion of the dissertation. It includes a summary of the findings, the 






1.8.  Summary 
The chapter presented an overview of the study. A review of the available literature revealed 
that there is a scarcity of information relating to the prevalence of hearing loss in school age 
children- infected with HIV/AIDS in South Africa. The researcher aims to investigate the 
audiological profile of HIV infected children to ascertain the prevalence of hearing loss and 
review medical management received by these children infected with HIV/AIDS attending an 





















CHAPTER 2:  HIV/AIDS AND HEARING LOSS IN CHILDREN 
2.1. Introduction  
This chapter will focus on the HIV/AIDS mode of transmission, its classification system as 
well as the impact of the virus on the auditory system. The effect of hearing loss on language 
development, and academic performance will also be highlighted. In addition, the medical 
and audiological management strategies of hearing loss in children will be discussed, while, a 
brief description of audiological testing protocol for school age children will be presented. 
 
2.2.  HIV/AIDS mode of infection in children  
AIDS is a disorder in which the immune system is unable to defend itself against various 
infectious agents, and develops as a result of the Human Immunodeficiency Virus [World 
Health Organisation (WHO, 2008)]. In a world that is dealing with the epidemic, children are 
not excluded from the challenges related to HIV. Children can be infected with HIV/AIDS as 
a result of sexual abuse, being care takers of infected parents, occult related sexual practices 
using children, nasocomial infection (hospital infection through the use of unsterilized 
infected equipment), and through vertical transmission i.e. mother to child transmission 
(MTCT) (Graber et al., 2008; Gross et al., 2007).  
 
MTCT is the prevalent mode of infection in young children, and the virus can be transmitted 
during pregnancy, delivery or after birth during breast feeding (UNICEF, 2012). According 
to Trotta, Meli, Ginelli, Sbanagli and Leoncini (2000), 95% of paediatric HIV infections are a 
direct result of vertical transmission from mother to child due to maternal factors such as 
immune status (CD4 count), and  vitamin A deficiency (Mueller & Pizzo, 1997). The 
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mother’s high viral load levels can result in HIV infection, and this increases the chances of 
the infection being transmitted to the unborn child (Olusanya, Afe, & Onyia, 2009). In 
addition, behavioural factors such as smoking, drug consumption and unprotected sex during 
pregnancy have been reported to contribute towards MTCT (Trotta et al., 2000). Literature 
has also included obstetrical factors such as placenta infection, and prolonged rupture of 
membrane during labour resulting in the infection of the child (WHO, 2006).  Infant factors 
such as foetal trauma, prematurity and breast feeding without the use of Ziddovudine (AZT) 
by an infected mother, may also contribute towards a high prevalence of MTCT (WHO, 
2006). All these factors render the child’s immunity compromised and the virus then destroys 
the immunity resulting in the disease progressing to the next stage (Mueller & Pizzo, 1997). 
 
As the immunodeficiency progresses, HIV develop into AIDS through stages, namely the 
early, intermediate and final stages (Matas et al., 2006). The stage progression results in the 
inability of the human body to defend itself against opportunistic infections (Abrams et al., 
2006).  Extensive research has been conducted to better understanding of the virus workings 
in the human body, and its effect on the function of the immune system (Graber et al., 2008). 
This resulted in a profiling of the immunity degeneration and hence the need for HIV specific 
disease classification. Due to the disease profile, further investigations were required 
resulting in the Centre for Disease Control and Prevention (CDC) formulating a unique 








2.3. Disease classification  
During the early 1980’s, the CDC devised a definition for AIDS monitoring (Lindergren et 
al., 2006). This was accomplished by profiling a group of HIV infected adults according to 
their disease symptoms (Lindergren et al., 2006). Due to initial inadequacies, the system had 
to be revised in the adult population to accommodate the initial shortcomings. However, the 
adult classification system did not account for the complexities of the paediatric immune 
system. Therefore, further modification to the existing classification methods were required 
to suit their diverse needs (Bankaitis & Schountz, 1998). According to Bankaitis (1998) and 
CDC (1994), this classification system was inadequate due to the following reasons: 
 Detecting the sensitivity of HIV positive or negative antibodies in an infant’s blood 
was not possible as the antibodies could be passively transmitted to the infant from 
the HIV infected mother and persist for up to 15 months (Krogstad, 2006). This 
suggested that the infants of HIV positive mothers will test positive at birth, although 
only 15-20% will actually become infected. HIV positive or negative infants will 
serorevert more than a year later (CDC, 2009).  
 Infants up to 15 months who were prenatally exposed to the virus through their 
infected mothers were considered HIV positive by meeting at least one of the 
following criteria: virus detection in the blood or tissue, presence of HIV antibodies 
with evidence of cellular and humoral immune deficiency and the development of 
symptoms meeting the CDC, 1993 definition of AIDS (CDC, 1994). 
 
In the new classification, children are assigned to four mutually exclusive clearly categorized 
groups numbered 1 to 4 (Lindegren et al., 2006). This also includes the use of CD4+ 
14 
 
lymphocytes count change and percentage of CD4+ lymphocytes (UNICEF, 2012). The 
additional parameters included: 
(1) Infection status, where three levels appear ranging from 1 to 3 indicating the 
progression of the disease; where 1 indicates no infection, 2 indicates mild infection, 
and 3 indicates severe infection (Krogstad, 2006). 
(2) Immunological status, which was further categorized into symptoms that were 
graded from N1 (which indicated no evidence of immunosuppression) to N3 
(indicating severe immunosuppression status) (Krogstad, 2006). 
(3) Clinical status, which ranged from mild-severe status, where A indicates mild, B 
indicates moderate, C indicates severe and N indicates no symptoms (Bankaitis et al., 
1998).  
 
This, therefore, suggests that children’s immunity responds differently to the virus as 
compared to adults, making them more susceptible to infection, even if they present with high 
CD4+ T-cell counts (Bankaitis et al., 1998) . It is reported that the latency period is shorter in 
children, with disease progression being more aggressive with associated side effects in the 
different disease stages (Hugdson & Montgomery, 2008).. One therefore, needs to be 
cognisant of these differences when managing children with HIV as treatment that is offered 






2.4. Medical management of children with HIV/AIDS 
One of the recommended management strategies to fight HIV and to improve the immune 
system is through the administration of Antiretroviral (ARV) medication (Abrams et al., 
2006). In 2004, the National Antiretroviral Treatment guidelines were released in South 
Africa. There are 3 main classes of antiretroviral agents which form part of the management 
strategy: 
1. Nucleoside analogue reverse transcriptase inhibitors (NRTIs) are inclusive of 
drugs such as AZT (ziddovudine or ZDV), Didanosine (ddl), Lamivudine (3TC) 
and Stavudine (d4T) (Engud et al., 1997). These drugs are designed to block the 
action enzyme of the virus, reverse the transcriptase phase and, thereby, prevent 
the virus from using the host DNA to reproduce itself (WHO, 2006).  
2. Non-nucleoside analogue reverse transcriptase inhibitors (NNRTI’s) include drugs 
like Nevirapine and Efavirenz (Mofenson & Serchuck, 2006). The role of these 
drugs includes blocking the action of the enzyme Reverse Transcriptase, and 
thereby, preventing the virus from using the host DNA to reproduce itself (Farley, 
2006).  
3. Protease inhibitors (PIs) include Ritonavir, Nelfinavir, and Lopinavir/Ritinavir 
(Keletra) (Mofenson & Serchuck, 2006). The function of these drugs is to block 
the enzyme protease, preventing the virus from making new copies of itself.  
 
 Locally clinical practice of HIV Medicine KZN Step by Step Guide for Management of 
Children on ART (2010) which recommends the following indicators be used to determine 
when to commence ARV treatment: 
 CD4 <350cell/mm3 irrespective of the stage 
 WHO stages 3 and 4 AIDS-defining illness, irrespective of CD4 count 
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 Patient expressing willingness and readiness to adhere to treatment (KZN Department 
of Health, 2010). 
 
The prescribed drug regimen for children with HIV is intended to minimise the viral load in 
the blood stream, resulting in reduced disease burden and a stronger immune system. This is 
in keeping with international practices and the goal is to prolong life, improve quality of life 
and to save lives (WHO, 2006). The current prescribed drug regimen, as recommended by the 
KZN Department of Health (2010), is:  
 Line 1 drugs i.e. Abacavir (ABC), Lamivudine (3TC), Efavirenz (EFV), and Stocrin. 
 Line 2 drugs i.e. Zidovudine (AZT), Didanosine (ddI), and LPV/r (Kaletra). 
For children with TB the recommended regimen is Abacavir (ABC), Lamivudine 
(3TC), Efavirenz (EFV) and Stocrin. 
Giaquinto et al. (2008) described uncertainties and challenges when prescribing antiretroviral 
drugs as part of the medical management of children with HIV. These included selecting the 
most appropriate regimen for an individual child which depends on a variety of factors. These 
factors include the age of the child, the availability of appropriate drug formulations, the 
potency, complexity and toxicity of the drug regimen, the home situation, the child and 
caregiver’s ability to adhere to the regimen, and the child’s antiretroviral treatment history 
(Giaquinto et al., 2008). As is evident ototoxicity is, unfortunately, not prioritised. 
 
2.5 Ototoxicity as a result of life prolonging antiretroviral drugs 
Since the introduction of Highly Active Antiretroviral Treatment (HAART) to manage the 
virus, other complications have been reported.  These include peripheral and central auditory 
pathway abnormalities and hearing loss (Giaquinto et al., 2008).  Bankaitis and Schountz 
(1998) reported that antiretroviral medication used in conjunction with other drugs, could 
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result in ototoxicity through drug interactions, and ultimately a permanent sensorineural 
hearing loss. Ototoxicity refers to the injury of the cochlea or vestibular system from frequent 
use of drugs resulting in an irreversible hearing loss (Schmelzele, Birthwhistle & Tan, 2008). 
Gurney and Murr (2003), reported that antiretroviral medication such as zidovudine (AZT), 
dideoxyctidine (ddC), Ritonavir(novir), Saquinavir (invarasse), and Epivir (3TC), are 
ototoxic and can result in permanent sensorineural hearing loss with associated vertigo, 
nausea, vomiting and ataxia. Most of these drugs are prescribed for HIV positive children, 
indicating the need for audiological monitoring for hearing loss due to ototoxicity (Gurney & 
Murr, 2003).   
 
 Antiretroviral drugs are used to manage the virus levels in the blood stream, in order to 
improve immunity, giving resistance against opportunistic infections like otitis media, TB, 
meningitis and syphilis. These infections will require additional drugs to combat the 
infections, which result in a higher number of drugs being taken by children infected with 
HIV/AIDS (Graber et al., 2008). This has a negative effect on the already compromised 
immune system (Post, Badri, Wood & Maartens, 2001; Harris et al. 2012) with the drug 
interaction resulting in adverse effects on the auditory system. According to Harrist et al., 
(2012), ototoxicity prevalence has increased, especially with HIV, tuberculosis and cancers; 
thus, highlighting the urgent need for audiological services for holistic patient management.  
 
The audiologist should, therefore, not view auditory disorders associated with HIV in 
isolation, but rather consider holistic management by early identification to prevent the 
adverse effects of drug reactions and ototoxicity induced by drug overload (Harris at al., 
2012). This impacts on the audiological services required, as the patient presentation becomes 
complex and requires holistic management (Mathew et al., 2012).  One can therefore assume 
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that audiologists are essential in   the management to minimise the negative effects of hearing 
loss on communication (Harris et al., 2012).  
 
All children with HIV/AIDS should undergo audiological evaluation to assess if the auditory 
pathway has not been affected, even though they do not present with obvious signs of a 
hearing loss, as subtle audiological and neurological changes have been reported in children 
who are asymptomatic (Matas et al., 2010).  Matas et al. (2010) reported that due to the 
growing incidence of hearing loss in HIV positive people, audiological as well as 
electrophysiological investigations of hearing should be conducted to detect the alterations of 
the peripheral and central auditory pathways as the HIV progresses to the AIDS stage. 
 
Miziara, Weber,  Cuhna, Filo, and Neto (2006), reported that hearing loss due to ototoxicity 
was high and ototoxicity required aggressive means of early audiological monitoring. The 
researchers recommend that audiological monitoring be achieved by conducting a hearing 
test battery, inclusive of pure tone frequencies ranging from 250Hz to 12000Hz, Otoacoustic 
emissions (OAE) and ABR, as this has been established to be best practice in audiology 
(Rapport, Fausti, Schechter, Frey, & Hartigan, 1985; Khoza-Shangase, 2011).  The 
audiological test battery used to assess ototoxicity associated with HIV/AIDS needs to be 
sensitive enough to identify subtle changes in the auditory status.  
 
2.6. HIV/AIDS and effects on the auditory system 
The AIDS disease has been reported to progress from stage to stage, accompanied by 





Table 2.1  
Stages of AIDS disease progression and symptoms  
Stage Laboratory evaluation Clinical symptoms 
 Stage 1 CD4+ count of > 
500cells/mm3 
 Lymphadenopathy 
 Significant abdominal and mediastinal 
lymphadenopathy 
 Dermatological abnormalities 
 Oral lesions 
 Recurrent respiratory infections. 
Stage 2 CD4+ count of 200-
500cells/mm3 
 TB 
 Bacterial pneumonia 
 Oral lesions 
 Chronic disease 
 Serous bacterial infections 
Late stage CD4+<200cell/mm3  Disseminated TB 
 Opportunistic infections e.g. extra pulmonary TB 
 Fatigue, weight loss becomes worse 
 Severe neurological complications 
 Human papilloma virus 
 Haematological abnormalities 
Adapted from:  Moragan, Mahe, Manyanja,  Okongo, Lubenga, & Whiteworth. (2002); Post,  Badri, Wood, &  Maartens, ((2001).  
 
Due to the immune system being compromised, the individual is susceptible to various types 
of opportunistic infections, including otologic infections that could result in a hearing loss 
(Mueller & Pizzo, 1997). Paediatric patients are prone to opportunistic infections and 
neurological complications that can compromise the auditory and vestibular systems 
(Matthews et al., 2012), and which can negatively impact communication (Palacios et al., 
2008). Due to the weaker immune system, the individual will become susceptible to various 
infections as the disease progresses (Graber et al., 2008). The critical factor to consider is the 
stage of the disease, the clinical symptoms and susceptibility to infections. 
 
Opportunistic infections such as bacterial meningitis, tuberculoma meningitis, CMV, Epstein 
- Barr virus, and streptococcal meningitis are common in the HIV/AIDS infected population 
(Kutz, Simon, Chennupati, Giannoni & Manolidis, 2006). Other opportunistic and viral 
infections such as tuberculosis, Pneumocystis carini, cryptococcal meningitis and Herpes 
Zoster have been reported to affect the auditory and vestibular systems, resulting in hearing 
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loss that requires audiological intervention (Bankaitis & Schountz, 1998). Auditory and 
vestibular complications that arise as a consequence of HIV related opportunistic infections 
can be defined as otologic conditions associated with HIV/AIDS. Otologic conditions 
associated with HIV/AIDS may give rise to conductive, mixed or , sensorineural hearing loss 
or auditory deficits related to central pathology (Abrams et al., 2006).  Otologic conditions 
together with site of lesion and management strategies are described in Table 2.2. 
 
Table 2.2  
Audiological and vestibular complications associated with HIV/AIDS  
Component Disease Manifestations  Proposed treatment 
Outer ear Candida albicans 
Otitis externa 
Dermatological infections 
Normally appearing in the 
oral cavity but can be found 
in the auditory canal. This 




includes removal of 




Middle ear Otitis media and perforated 
tympanic membrane, 
Recurrent otitis media associated 
with chronic sinusitis, 
Serous otitis media associated with 
Eustachian tube dysfunction, 
Beginner nasopharyngeal 
lymphoid resulting in otitis media 
with effusion, 
Otomastoiditis 
Can result in a mild to 
profound hearing loss that 
is unilateral or bilateral. 
This can result in a 





Inner ear Ototoxicity and opportunistic 
infections (like bacterial 
meningitis, tuberculoma 
meningitis, cytomegalovirus, and 
co-infection, Epstein - Barr )that 
can result in temporary or 
permanent hearing loss 
Damage to hair cell 
function in the cochlea, 
resulting in an irreversible 
hearing loss that could be 
unilateral or bilateral. This 
can result in a sensorineural 
hearing loss. 
Medical intervention 






Vertigo, ataxia, occulomotor 
changes, pathogens in the temporal 
bone resulting in cytological 
changes 
Vestibular changes 
associated with equilibrium 









The most common pathologies resulting in conductive hearing loss are otitis media, 
mastoditis, tympanic membrane perforation, and recurrent otitis with effusion (Abrams et al., 
2006). Sensorineural hearing loss could result from damage to the cochlea (sensory 
component) and/ or the  auditory nerve (neural component) (Copley & Frederichs, 2010). 
Viral or bacterial infections such as Cryptococcus meningitis, toxoplasmosis, meningitis, 
cytomegalovirus, and herpes can result in a sensorineural hearing loss (Carney & Muller, 
1998). Central nervous system neoplasm and ototoxicity have also been reported in children 
infected with HIV/AIDS. Furthermore, the pathologies causing conductive, sensorineural and 
central hearing loss will also result in varying degrees and symmetry of hearing loss (Abrams 
et al., 2006). Due to disease progression, audiological complications resulting from 
HIV/AIDS infection also manifest with undesirable effects on language development, 
scholastic performance and vocational opportunities (Hausler, Vibert, Koralnik, & Hischel, 
1991). Therefore, to better understand the complexities of the auditory effect it is important to 
be aware of the prevalance, possible causes and impact of the virus as related to children. 
 
 
2.7. Epidemiology of hearing loss 
The reported prevalence of hearing loss associated with HIV/AIDS varies across the 
spectrum internationally and locally for adults and children (Khoza & Ross, 2002). 
Internationally, the reported prevalance of hearing impairment in children with HIV/AIDS 
varies from approximately 20% to 40%. In South Africa, while approximately 2.4 % of 
children under the age of 14 were reported to be living with HIV/AIDS, there is no data 
available of the percentage presenting with a diagnosed hearing loss (Matas et al., 2010; 
Prevalence, 2010).  In the absence of accurate statistical data in South Africa, one can 
conclude there are varying prevalance rates relating to hearing loss associated with 
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HIV/AIDS.  This indicates a need for a study that will focus on investigating the audiological 
profile and prevalence of hearing loss in the 4% of children living with HIV in South Africa 
(Khoza-Shangase, 2010). This will inform audiologists on the prevalence and the description 
of hearing loss in children relating to hearing loss type, degree, configuration and symmetry.   
 
2.8. The prevalence of middle ear pathology in immunocompromised children 
A study by Shapiro and Novelli (1998) indicated that 44.4% of the participants presented 
with one or more episodes of middle ear pathology, including otitis media. While the results 
of a pathogen type of immunocompetent children were similar to the general population of 
children not infected with HIV, the results suggested that severity of immunosuppression was 
associated with higher incidence of middle ear pathology. This is in keeping with Post et al. 
(2001) and Principi et al. (1991) who reported that children with low immunity and high viral 
load were prone to present with more episodes of middle ear pathology; making them prone 
to hearing loss. In addition, Principi et al. (1991, p. 560) reported that “HIV infection does 
not modify the occurrence of otitis media, but it was more common in HIV infected 
children”. 
 
A study by Miziara et al. (2006), assessed the changes in the prevalence of otitis media 
associated with the use of HAART in Brazil.  Miziara et al. (2007) reported a prevalence of 
10.5% for acute otitis media, 14.2% for chronic otitis media and 8.5% for serous otitis media; 
thus, suggesting a high prevalence of middle ear pathology in immunocompromised children. 
The study also highlighted that recurrent middle ear infections were more frequent in 
symptomatic children and possibly conductive hearing loss.  Principi et al. (1991), and 
Shapiro and Novelli (1998), highlight that children who are immunocompromised tend 
reported to have a high prevalence of middle ear pathology. However, such findings have not 
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yet been published in South Africa and there is a need to report on this in HIV positive 
children, to better understand the role of the viral load on the auditory system and the medical 
management strategies required.   
 
2.9. Medical management for middle ear related pathology in HIV infected children 
Antibiotic (antimicrobial) treatment is the most common first line choice of management of 
middle ear pathology in children with HIV/AIDS. Antibiotics can cause ototoxicity as they 
can penetrate the middle ear through the ventilation tubes or perforated tympanic membranes 
since a recommended treatment method is with ear drops (Choung et al., 2008). Alternatives 
to antibiotics include topical aminoglycosides (such as selfrodex) as indicated earlier in Table 
2.2. However, when administering such drugs, a limited duration is required as they are 
highly ototoxic (Gibney, Morris, Carapetis, & Skull, 2005).  
In addition, literature has established that the combined use of aminoglycosides and 
antiretroviral medication will result in severe ototoxicity with an associated hearing loss, and 
must be avoided in the clinical management of children with HIV presenting with middle ear 
pathology (Gurney & Murr, 2003). Therefore, a conclusion can be reached that monitoring 
for ototoxicity and early identification of hearing loss by an audiologist should be mandatory 
to prevent permanent and irreversible ototoxic hearing loss (Jacob, Aguiar, Tomiasi, 
Tschoeke & Bitericourt, 2006). Beside the antibiotic treatment procedure, there are surgical 
procedures available for the management of children infected with HIV. Children with 
HIV/AIDS are reported to present with reduced rates of spontaneous recovery from middle 
ear pathology (Beigh et al., 2012). Though the recovery intervals are protracted in HIV 
positive children and medical and audiological intervention is necessitated, literature has 
suggested the use of virus levels in the body and immunity resistance measures can play a 
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positive role in the early identification of individuals who are susceptible to opportunistic 
infections that can cause in hearing loss (Srugo et al., 1991). 
 
2.10. The use of CD4cell count and viral load count as indicators for audiological 
monitoring 
Srugo et al. (1991) reported a positive correlation between disease burden and CD4 count and 
that symptomatic children carry a higher amount of virus in the plasma than asymptomatic 
children. It can, therefore, be concluded that viral load and CD4 count seem to have a direct 
correlation to susceptibility to infections, including otologic conditions that will affect 
hearing.  
 
Palacios et al. (2008), reported that audiological abnormalities were more frequent in patients 
with more prolonged HIV-1 infections, higher viral loads, or lower absolute CD4+ cell 
counts. The authors correlated a lower CD4 cell count to auditory pathology and reached the 
conclusion that immunocompromised children are susceptible to otologic infections. It also 
suggested that CD4 cell count measurements can be linked to repeated rates of infections. 
Low CD4 count measures have been associated with compromised immunity and high 
disease burden as an indicator for susceptibility to conditions that affect the auditory system 
(Maziaria et al., 2007). This can be associated with a compromised immune system that can 
be identified through the CD4cell count and viral load blood measurements, which are carried 
out routinely for children with HIV/AIDS to monitor disease burden (Principi et al., 2001). 
CD4 cell count and viral load measures can be used as indicators for the need for audiological 
monitoring, as these measures indicate the disease burden and negative impact on the 
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immune system’s ability to resist infections that can affect the auditory system (Bojrab, 
Bruderly & Abdulrazzak, 1996). One can, therefore, conclude that CD4 cell count and viral 
load measures can also be used to indicate susceptibility to auditory based pathology. 
 
Principi et al. (1991), Shapiro and Novelli (1998), Srugo et al., (1991), and Palacios et al., 
(2008)  conducted studies internationally, and indicate a scarcity of research  in the paediatric 
population (Khoza- Shangase, 2011). There are limited published findings  in South Africa 
that report on the auditory status of HIV infected children and there is a need for such 
research to be published (Morgan et al., 2002). Therefore, conducting an audiological profile 
study and reporting on the medical management will assist in adding to the literature 
available which is relevant to the South African context.  
The consequence of limited availability of research that reports on the prevalence of otologic 
conditions in immunocompromised children highlights the need for urgent reporting on this 
population. There is a lack of data that directly links hearing status (in terms of hearing loss 
degree, type, and symmetry) with CD4 cell count levels and otologic conditions (Palacios et 
al., 2008). This will benefit the profession of audiology, as children with a low CD4 count or 
high viral load are monitored for middle ear pathology early and receive hearing evaluations 
timeously. Children with severe immunosuppression are likely to present with otologic 
conditions that will affect the hearing and subsequent language and scholastic development 
(Feagans et al., 1994). If the middle ear pathology is not managed, the infection can spread to 
the cochlea and the auditory nerve, resulting in damage to the middle and inner ear 




2.11. The effects of the virus on the inner ear and cortical structures  
Damage to the inner ear as a result of infections, trauma, exposure to excessive noise for long 
periods and ototoxicity will result in a sensorineural hearing loss (Gelfand, 2001). Matas et 
al. (2006) reported that sensorineural hearing loss (SNHL) can affect 21% - 49% of people 
living with HIV/AIDS, and sensorineural hearing loss is permanent and irreversible.  HIV is 
reported to affect the inner ear, as the virus has been reported to be neurotropic and can 
present with neurological symptoms (Lasis, 2005). Viral agents have been reported to attack 
the spiral ganglion and acoustic section of the eighth cranial nerve resulting in sudden onset 
of a permanent hearing loss (Gross et al., 2007). The viral agents include cytomegalovirus 
(CMV), hepatitis B, herpes simplex, syphilis, herpes zoster and toxoplasmosis due to the 
compromised immunity (Sweeney & Harris, 1996). To effectively manage bacterial and viral 
infections as a result of the opportunistic infections in immunocompromised children, 
antibiotics and antiretroviral drugs have been reported to be ototoxic, compounding the 
severity of the SNHL (Khoza-Shangase, 2010). 
 
In addition, it was initially believed that the virus affects only the immune cells of the body, 
and further research has indicated that the virus also attacks and destroys the central nervous 
system (CNS), with an estimated 10%-30% of people with HIV presenting with neurological 
abnormalities (Makar, Dhara, Sinha, Chatterjee, & Dutta, 2012; Khoza-Shangase, 2010; 
Matkin et al., 1998; Sweeney & Harris, 1996). Paken (2007) confirmed that there are 
neurological changes in normal hearing adults with HIV/AIDS. The neurological 
abnormalities can also be associated with the hearing related problems, with reports of 
auditory processing deficits, central hearing loss and auditory brainstem disorders which 
negatively affect language development and communication (Makar et al., 2012). 
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Neurological complications can manifest in young children through failure to attain 
developmental milestones with the most prominent milestone being language delay and 
cognitive impairment. These manifestations have been associated with cranial neuropathy, 
progressive encephalopathy, microcephaly, meningitis and neoplasm, and are reported to 
occur between the age of 6 months and 5 years, which is during the language acquisition 
phase (Hausler et al., 1991). 
 
2.12. The effects of hearing loss on language development in children 
Hearing loss, irrespective of cause, type, and degree has adverse effects on linguistic 
development in children (Cook et a1., 1998). Zumach et al. (2010) reported that language 
development is critical during the early childhood years and the American Speech and 
Hearing Association (ASHA) (1997) supported that hearing loss impacts on the development 
of speech, language, social, emotional, cognitive and academic progress. Hearing loss has a 
negative impact on the different components of language such as syntax, semantics and other 
basic verbal skills (Feagans et al., 1994). A reduction in auditory input causes challenges with 
the imprinting of speech language in the developing brain, as hearing loss alters the linguistic 
cues, the child misses out on spontaneous opportunities to hear language by means of  adult 
demonstration during the early language acquisition phase (Carney & Muller, 1998). In 
addition, these children present with delayed receptive and expressive vocabulary, poor 
grammatical skills, and delayed grasping of concepts (Makar et al., 2012). They present with 
poor linguistic based pragmatic skills resulting in limited opportunities to use language 
appropriately in a social context (Olyer, Oyler, & Matkin, 1998). This results in generalised 





Speech production is considered to be affected, when articulation, vocal prosody, intonation 
patterns, and timing have been affected (Cole & Flexer, 2007). This can result in  poor 
expression and understanding by the communication partner (Flexer, 1994). Consequences of 
global delay in receptive and expressive skills can result in challenges with social interaction, 
and reports of behaviour problems are significantly higher in children with a hearing loss 
(North-Matthiassen & Singh, 2006). In addition, behaviour problems can lead to isolation, 
depression and poor acceptance into the community (Hugdson & Montgomery, 2008; Smith 
et al., 2008 ).  Language is essential for thinking, communication and learning. Hence, the 
presence of a hearing loss in the early years of life may result in gaps in the acquisition of 
learning, poor knowledge acquisition and cognitive impairment (Feagans et al., 1994). One 
can, therefore, conclude that if hearing loss affects speech-language development in children 
without HIV/AIDS, the same fate will be suffered by children with HIV/AIDS (Govender et 
al., 2011). However, hearing loss identified and managed early (within the first 6 months of 
life) can result in normal language acquisition (Swanepoel, 2007). One can conclude that by 
improving access to language by managing hearing loss, even children with HIV presenting 
with neurological impairment will be given a better chance to develop language normally as 
long as the auditory system is not compromised. Further early intervention  can be provided 
to counter auditory deprivation  from hearing loss, and thus minimise the negative impact on 
language development and on academic performance (Harris et al., 2012). 
 
2.13. The negative impact of hearing loss on scholastic performance 
Hearing loss in the school age population has an adverse effect in the classroom and other 
listening environments, as auditory dysfunction affects perception and understanding of 
speech sounds (Niskar, et al., 1998).  Early onset of any hearing loss could result in reduced 
processing at the lower brainstem and cortical levels in subsequent years (Maruthy & 
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Mannarukrishniah, 2008). Auditory processing deficits may manifest as poor concentration, 
auditory recall, auditory analysis and synthesis. These aspects are, however, essential for 
reading and writing abilities (Feagans et al., 1994). Therefore, language and auditory 
processing deficits, resulting from a hearing loss, can interfere with the successful acquisition 
of literacy skills (Carney & Muller, 1998). Children with reading fluency problems associated 
with hearing loss also present with difficulties in reading comprehension (Chandrasekhar et 
al., 2000). It is, therefore, imperative that early identification of hearing loss be established to 
improve academic performance and vocational potential of each child (Paluski & Kaderavek, 
2002). 
 
One can deduced that to ensure that all children, including those with HIV related hearing 
loss, be given a fair and equal opportunity to achieve academically, hearing loss must be 
timeously managed so that it does not affect their autonomy and independence as adults 
(Broste et al., 1989). Early diagnostic certainty is crucial in school age children, especially 
those infected with HIV as they are prone to hearing loss (Broste et al., 1989). Therefore, the 
audiologist must be involved in the early management to minimise adverse effects of hearing 
loss on academic performance. Audiologists should therefore, intervene where auditory and 
vestibular impairments have been identified, to reduce the negative impact of hearing loss on 
language development, and scholastic development, and to improve the chance of vocational 
opportunities. In South Africa, there is limited research on the impact of hearing loss on the 
paediatric population infected with HIV/AIDS, highlighting the need to establish an 
audiological profile of the HIV infected children who are affected. In addition, this will 
advocate for a prominent role of the audiologist in the multidisciplinary management of HIV 
to minimise the negative effect on scholastic performance, which will have a bearing on 
vocational opportunities later in life (Khoza-Shangase, 2010; Matas et al., 2010).  
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2.14. Audiological management of children presenting with a hearing loss  
Studies show that children with HIV presenting with otologic infections tend to present with 
a protracted course of infection, and the possibility of spontaneous recovery is limited due to 
the compromised immune system (Gold & Tami, 1998).  Generally, audiologists tend to 
delay fitting of hearing aids, as they are waiting for the resolution of the middle ear pathology 
(Choung et al., 2008). It therefore appears that children infected with HIV/AIDS who have an 
associated hearing loss, require immediate amplification, and amplification should not wait 
until  the middle ear pathology resolves (Diefendorf et al., 1990), as a hearing loss can lead to 
auditory deprivation which will result in the loss of linguistic input and subsequent delayed 
linguistic development (Cole & Flexer, 2007; Northern & Down, 2002). The recommended 
guidelines from literature relating to counselling, hearing aid selection, fitting, hearing aid 
verifications and validation should be implemented indiscriminately for all children including 
those who are immunocompromised (Dillon, 2001). However, special consideration for 
amplification should be made with immunocompromised children.  
The goal of amplification is to enable audibility of speech and environmental noise which 
will allow for improved auditory input, including language (Evans, 2005).  This can be 
achieved through the selection of the amplification characteristics that will include the style 
of hearing aid, as behind the ear (BTE) hearing aids are recommend for children. They are 
robust and allow for additional power in the device (Evans, 2005). While selecting the 
appropriate hearing aid style is crucial, the technology inside the device is more important. 
Evans (2005) advocates that children should receive the latest hearing aid technology 
available.  
Hearing aids with advanced signal processors are available (Dillon, 2001). The technology 
should be carefully selected when considering hearing aids for children including those with 
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HIV, to provide maximal benefit (Evans, 2005).  One can assume that  immunocompromised 
children are prone to middle ear infections, alternatives to air conduction hearing aids are 
available in the form of bone conduction hearing aids (BCHA) and implantable bone 
conduction hearing aids (IBHA), but these are not cosmetically appealing, and require careful 
consideration (Hughes, 1995). BCHA are used with conductive hearing loss that otherwise 
cannot use the conventional air conduction hearing aids and moreover to minimise the 
development of opportunistic infections resulting from pressure sores. BCHA are widely 
available in South Africa, as they are affordable and easy to fit since they do not require 
custom ear moulds (Dillon, 2001).  However, due to pressure sores associated with prolonged 
use, headaches and poor cosmetic appeal, compliance in terms of wearing the devices has 
been reported to be poor in the paediatric population without HIV (Dillon, 2001) and it is, 
therefore, likely that similar challenges could be reported in HIV infected population. 
Audiologists should be cognisant that in children infected with HIV pressure sores, 
associated with the use of BCHA could result in other opportunistic infections which could 
consequently result in the patient not using the device.   
While, IBHA can be an alternative to BCHA, but there is a strict candidacy guideline for this 
type of device due to associated costs (Goebel et al., 2002).  Unfortunately, these devices are 
costly and not widely used in the South African context; thereby, rendering them as a limited 
option to children infected with HIV who are poor candidates for surgery and prone to poor 
wound recovery (Principi et al., 1991). Audiologists, therefore, need to carefully consider the 
type of device selected to maximise benefit to the patient with a restricted budget. While 
these services are offered by audiologists in the South African public sector, the clinicians are 
required to use the most effective,  accurate and cost effective tools (Matas et al., 2010) to 
identify and manage hearing loss amongst school age children who are receiving ARV 
treatment with budgetary constraints..   
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Emphasis has been on the medical model of service delivery and little attention has been 
given to quality of life factors (Friedman & Noffsinger, 199). This is evident when one 
reviews the  current policy on HIV/AIDS, as stated by the National AIDS Foundation (2009) 
which  identifies  doctors, nurses, pharmacist, social workers, psychologists, counsellors and 
dieticians as crucial team members. The policy has identified these professionals and their 
roles and responsibilities in the management of people living with HIV. Regrettably, 
audiologists have been excluded from the team, even though they are the designated 
professionals responsible for the auditory and vestibular system. The audiologists’ expertise 
has not been clearly understood and their significance in assessment, management and 
prevention of otologic conditions that impair communication including those that result from 
HIV/AIDS related conditions are underestimated requiring further research (Hall & 
Swanepoel, 2010); thus one can conclude that there is a need for a study to report on an 
audiological profile and audiological management of children with HIV/AIDS with 
associated hearing loss.  
 
2.15. Audiological profiling in the context of hearing loss associated with HIV/AIDS 
Internationally, research has focused trends on establishing hearing related profiles by 
describing prevalence of hearing loss in HIV/AIDS infected children. A study by Weber et al. 
(2006) in Brazil is an example of profiling. The study aimed to report on the prevalence of 
otitis media in children with HIV on HAART versus the children on ARV only. The results 
revealed that 65 of the participants (14.2%) aged between 0-5.11years on HAART had 
significantly lower prevalence of chronic otitis media than those children on ARVs.  The 
Weber et al. (2006) study results highlighted that the use of HAART reduced the prevalence 




Miziara et al. (2007) conducted a study in Brazil where they assessed the prevalence of otitis 
media associated with the use of HAART in HIV positive children. This study utilised a 
cohort of 459 children below the age of 13 years. The results revealed that otitis media had a 
prevalence of 31 % and therefore, use of HAART resulted in a lower prevalence of otitis 
media.  The age group studied in Miziara et al. (2007) study is similar to the current study. 
The current research will endeavour to provide a description of the prevalence of hearing loss 
in HIV positive children in the South African context to enable a comparison with 
international studies to establish if there are similarities or differences.   
 
Various studies have been conducted internationally on the hearing profile of school children; 
a prominent African study that was conducted by Olusanya et al. (2000) in Nigeria, where 
children aged between 4.5-10.9 years had their hearing assessed. The study profiled Nigerian 
school age children with the aim to establish the incidence of hearing disabilities in school 
children. The results revealed that 10% presented with slight hearing loss, 64% were found to 
have a mild hearing loss, 20% had moderate hearing loss and finally 6% had severe hearing 
loss. Of the 50 children with hearing loss, 36% presented with a conductive hearing loss, 
while 24% presented with sensorineural hearing loss and 40% presented with mixed hearing 
loss. The alarming finding from the study was that hearing loss was not detected or reported 
by the teachers and parents. The researchers reported that the lack of understanding of the 
impact of hearing loss on academic potential was the contributing factor to such high 
incidence of unreported hearing loss (Olusanya et al., 2000). A similar age range has been 
used in the current study, as these children still acquire language and are in the primary phase 
or foundation phase of their academic program, which is a crucial phase for further education.   
However, Olusanya et al. (2000) focused on the general population, with no mention of the 




In the South African context, research has also been conducted on the school aged population 
without HIV i.e. North-Mathiassen and Singh (2006). The research focused on “The Hearing 
Profile among Learners in Schools in the Western Cape” with the findings indicating that 
13.8% of the 1101 learners screened required referrals. The study highlighted that 
“establishing prevalence rates is important in determining whether a condition poses 
sufficient health risk to the population to warrant allocation of scarce resources to address it” 
(North-Matthiassen & Singh, 2006, p. 114). The conclusion stated that due to the high roll-
out of ARV, children are surviving longer and entering school, with the prevalence of hearing 
loss in school children being expected to increase. This is the most recent study that is 
contextually relevant and targeting the same population (school age) despite its focus not 
being primarily on children living with HIV/AIDS.   
 
In a study by de Lange (2007), on “A Hearing Profile of persons infected with HIV/AIDS” 
audiological assessments were conducted out on adults. de Lange’s study used similar 
audiological measures to evaluate hearing as the current study i.e. otoscopy, immittance 
audiometry pure tone audiometry, OAE and ABR. However, the approach and population are 
different. The results for the first sub-aim related to a profile of persons diagnosed according 
to the different clinical stages revealed that 78% had normal hearing, 15% had mild hearing 
loss, 6% had moderate hearing loss and 1% had moderately severe hearing loss. From the 
study results, 60% had normal hearing in the low frequencies, while 18% had conductive 
hearing loss, 18 %  had sensorineural hearing loss and 4% had mixed hearing loss for low 
frequencies due to sloping configuration. Pure tone audiometry results indicated hearing 
within normal limits but a decrease of hearing was noted with the progression of the disease 
for some of the participants. The concluding recommendations included hearing awareness 
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campaigns, improving audiologist’s knowledge on the effects of HIV/AIDS on hearing and 
inclusion of the audiologist in the management of patients with HIV/AIDS (de Lange, 2007). 
While, there are no published studies on audiological profiling for children with HIV locally, 
these national studies have alluded to the need to conduct further research in the paediatric 
population. 
 
In addition, another South African study conducted by Paken (2007) investigated the use of 
the ABR in detecting subtle and /or early neurological changes in HIV infected individuals in 
the three major groups of the 2003 CDC classification of CD4 cell count. The study 
concluded that ABR is able to detect subtle neurological changes in the HIV infected people 
and the study recommended that ABR should be used in the on-going monitoring for oto-
neuro diagnosis. 
 
Khoza-Shangase conducted numerous studies on HIV/AIDS and adults in South Africa. 
Khoza and Ross (2002), reported on “Audiological function in a group of adults infected with 
HIV/AIDS”, where the prevalence of hearing loss was described in terms of type, degree, 
configuration and symmetry following an exploratory non-experimental observational study. 
The results indicated that 23% of the participants had a hearing loss. Of these, 17 % of the 
participants presented with a conductive hearing loss, while 29% presented with mixed 
hearing loss and 54% presented with sensorineural.  The researcher reported that hearing loss 
was possibly resulting from opportunistic infections and associated treatment.  
 
Another study by Khoza-Shangase (2010) on monitoring the hearing status of adults on 
HAART revealed significant changes in high frequency hearing. This leads to the conclusion 
that patients on HAART require audiological monitoring. The current study will be similar to 
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Khoza and Ross (2002) in terms of ascertaining the prevalence of hearing loss being 
described in terms of type, degree, configuration and symmetry, but the target population will 
be different due to the scarcity of data in the paediatric population. 
 
 
2.16. Recommended diagnostic procedures for primary school age children  
Extensive literature related to hearing screening for school age children is available from the 
American Academy of Audiology (AAA) (2011), and American Speech and Hearing 
Association (ASHA) (1997). There are no specific guidelines for the 6-12 year olds in terms 
of diagnostic testing but there exists broad audiological guidelines for testing infants and 
young children (which includes school age children). Locally, the South African Speech 
Language and Hearing Association (SASLHA), together with the South African Association 
of  Audiology (SAAA) and the Health Professions Council of South Africa (HPCSA) have 
stipulated guidelines in terms of hearing screening in school children. Internationally and 
locally audiological guidelines recommend that practice for assessing auditory function in 
children include: 
 The implementation of various techniques must be evidence based and meet the needs 
of the child (Sabo, 2013). 
 The use of a test battery approach as a cross check principle to determine the 
audiological profile of children as recommended by Dworsack-Dodge et al. (2012). 
The final determination of hearing loss degree, type, configuration and symmetry 
should be based on the test battery approach and any discrepancies between the tests 
should be thoroughly investigated (Dillon, 2001). 
 Both behavioural (i.e. audiometry, and speech audiometry) and physiological 
measures (i.e. acoustic immittance inclusive of tympanometry and acoustic reflexes), 
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as well as OAEs and in some cases electrophysiological measures (i.e. ABR and 
Auditory Steady State Response (ASSR) testing needed to be utilised.  The clinician 
should ensure that accurate, and reliable results are obtained at all times (Gelfand, 
2001). 
 The gold standard of hearing measures is behavioural measures with pure tone 
audiometry as they establish hearing thresholds across the speech frequencies per ear. 
However, these are dependent on the child’s cognitive abilities, developmental age, 
and linguistic level, as well as visual and motor development in order to respond 
appropriately (North & Downs, 2002). 
 
General procedures should include case history and otoscopic examination, regardless of 
which tests are included in a specific test battery. In addition, immittance (tympanometry and 
acoustic reflexes both ipsilateral and contra lateral responses), conventional audiometry, 
speech audiometry, OAE, ABR and ASSR should be used. The current research has adhered 
to the recommended test battery with the exception of ASSR.  
 
2.17 Summary 
This chapter has highlighted the disease classification, mode of virus transmission in 
children, and reported on audiological profiling. Children who are immunocompromised are 
prone to otologic conditions that can result in a hearing loss (Krogstad, 2006). Emphasis was 
made on the need to consider CD4 cell or viral load as indicators of susceptibility to otologic 
infections and the necessity for early audiological management, due to the complex nature  of 
the disease in the paediatric population (Lindegren et al., 2006). Due to the nature of the 
virus, ARVs are prescribed however,  they suggest that ARV maybe  ototoxic (Khoza & 
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Ross, 2002). Therefore, audiological monitoring is mandatory to ensure that hearing 
impairment is minimised.  
 
Hearing loss, irrespective of the cause has negative effects on language development, 
scholastic success and finally vocational autonomy (ASHA, 1997). Therefore,  it is clear that 
the audiologist must play an active role in the identification and management of hearing loss 
in immunocompromised children to ensure an improved quality of life.  However, more 
investigations into the type of medical and audiological intervention strategies currently used 
for children who are immunocompromised are still required. This chapter has highlighted that 
medical management and audiological management is crucial, but due to the complexities of 
the disease, the audiologist should be cognisant of all the audiological strategies available to 
children with compromised immunity. This chapter has outlined the recommended 
audiological management guidelines used with children who are HIV negative and the 
challenges encountered when providing holistic management to children with HIV.   
 
Unfortunately in the South African context, HIV/AIDS policies have not included the 
audiologist as part of the multidisciplinary team, which in the view of the researcher has 
resulted in audiological intervention not receiving the necessary attention. Studies have 
indicated that the expertise of an audiologist is beneficial when they are included in the 
management of children with HIV/AIDS. 
 






CHAPTER 3: METHODOLOGY 
3.1.  Introduction 
This chapter describes the aim and objectives of the study, outlines the theory used to inform 
the research approach, as well as describes the study design and sampling technique used. 
The inclusion and exclusion criteria are provided, and the pilot study procedures highlighted. 
The data collection instruments, data collection process, data management, and data analysis 
are also elaborated on. The chapter also highlights reliability and validity issues and ethical 
and legal considerations of conducting a study of this nature.  
 
3.2. Aims and objectives of the study 
3.2.1. Aim of the study 
The aim of the study was to determine the audiological profile of school age children with 
HIV/AIDS at an antiretroviral clinic in KwaZulu-Natal.  
 
3.2.2. Study objectives 
The study had the following objectives: 
 To describe the prevalence and nature of hearing loss in terms of degree, type, 
configuration and symmetry. 
 To determine whether children with a hearing loss have received auditory related 
medical management and the type of treatment received.  
 To determine whether children with a hearing loss have received audiological 





3.3. Study design 
A non-experimental descriptive design which was exploratory in nature was used to achieve 
the objectives of the study to identify the occurrence of hearing loss, in school age children 
with HIV/AIDS (Greig Taylor & McKay, 2007; Shi, 2008; & Babbie, 2008).  The research 
followed a quantitative approach to examine the relationships between variables, and 
provides a snap-shot of characteristics of a specific group (Gravett & Forozo, 2009; Simon & 
Burstein, 1985). The relationship between variables could be expressed using statistical 
procedures such as correlations, relative frequencies, or differences between means (Hopkin, 
2008).  
There are many types of methodologies that can be implemented to produce the best results 
and measure these variables effectively. Methodologies refer to “the structural framework 
within a study implemented” (Drummon, 1996, p. 30). Epidemiology is an umbrella term 
used to define a study of diseases, utilising experimental or non-experimental study design 
(Berg & Latin, 2004). Prevalence is a sub-type of epidemiological study used to assess a 
number of cases of a disease in a population at a specific time (Drummon, 1996). The number 
of cases of a disease in a population can be further described using a profile, which entails a 
description of variables of the disease in a specific population (Hulley, Cummings, Browner, 
Grady & Newman, 2007). In the field of audiology, profiling has been used to describe the 
prevalence of hearing loss in a specific population (North-Matthiassen & Singh, 2006; de 
Lange, 2007; Khoza & Ross, 2002; Zakzouk & Hajjaj, 2002). For the purpose of the current 
study, audiological profiling was used to ascertain the prevalence of hearing loss in school 
age children infected with HIV.  The reasons for conducting a prevalence study were to 
assess the burden of disease in the population of children, report on the medical and 
audiological services offered, compare the prevalence of the condition in the local context 
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and internationally and to report prevalence trends or severity in a particular time frame 
(Drummon, 1996). ). 
3.4. Participants 
3.4.1. Study site 
Data collection was conducted at the Philani Family Clinic which is an ARV clinic at King 
Edward VIII hospital in KwaZulu-Natal, South Africa. This site was selected as it provides 
tertiary hospital services for children from the eThekwini District. As a result, the population 
being served is diverse in terms of ethnic groups, and residential areas. The Philani clinic 
attends to an average of 1750 children a month, majority of which are black African and 
operates daily during the week with a multidisciplinary approach to the management of 
children. The children attend the clinic on a monthly basis for medical intervention and to 
collect their medication (Dr. M. Achary, 2013).  
3.4.2. Sampling technique 
In quantitative non-experimental designs, non-probability sampling is recommended, as it 
does not include any random sampling (McMillan & Schumacher, 2001). Convenience 
sampling, which is a type of non-probability sampling, was used in the current study. The 
researcher used accessible participants with specific characteristics to meet the objectives of 
the study. In this study, the researcher aimed to understand the relationship between 
HIV/AIDS and hearing status (Maxwell & Satake, 1997).  
 
3.4.3. Study sample size 
Thirty participants were conveniently selected, as this is considered to be an adequate  
number of participants for an exploratory type of study using non-probability sampling 
technique  (Hulley, Newman, & Cummings, 2007; Mrs. Fikile Nkwanyana, 2014). A small 
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sample size was feasible due to time constriants, lack of research assistants, length of testing 
per participant and   late arrivals for the audiological testing. In addition, the participants 
were selected based on their availability, willingness to participate.  
 
3.4.4. Inclusion and Exclusion criteria 
The following inclusion criteria were adhered to: 
 All out-patients attending the Philani ARV clinic at King Edward VIII Hospital in 
Durban. 
 Aged between 6 - 12 years.  
 HIV positive with a confirmed medical diagnosis. 
Participant’s caregivers were willing to participate voluntarily and provided signed consent, 
with the child participant providing  signed assent. 
 
The following exclusion criteria were applied to the study: 
 In-patients were excluded due to ill health, as it may have affected  result reliability, 
 Adolesccents and adults were excluded as the focus of the study was on primary 
school going age. 
 Infants, toddlers and pre-schoolers were excluded from the study for the following 
reasons (Gelfand, 2001): 
- A second audiologist is required to confirm responses in the subjective behavioural 
audiological assessment. 
- Sedation is required for the electrophysiological measures and there are ethical-
legal considerations associated with sedation and time constraints involved. 




3.4.5. Description of the participants 
 A description of the study participants is presented in Table 3.1. The study sample comprised 
of 30 participants, which 17 (60%) were males and 13 (40%) were females, aged between 6-
12 years. All participants were Black African, according to the racial demographics and 
spoke isiZulu as a first language. 
 
Table 3.1.  
Demographic information of participants 
Age Gender 
Age in years Number Percentage Gender Number Percentage 
6 3 10.0% Male 17 60% 
7 5 16.7% Female 13 40% 
8 2 6.7% Race 
9 9 30.0% Black African 30 100% 
10 4 13.3%    
11 4 13.3%    
12 3 10.0%    
Total 30 100.0%    
 
 
3.4.6. Pregnancy, birth and developmental milestone history 
A detailed case history was obtained from the caregivers using a questionnaire developed for 
the purpose of this study. The information reflecting pregnancy, birth information, 
developmental history, medical history, hearing related problems, reported hearing difficulty; 








Pregnancy, birth history and developmental milestones 
Pregnancy and birth questions Response No responses 
 Yes % No % Number % 
Pregnancy and birth  
Full term pregnancy (n=30) 15 50% 7 23% 8 27% 
Healthy mother during pregnancy (n=30) 12 40% 8 27% 10 33% 
Types of deliveries  
Normal vaginal delivery (n=30) 14 46% 8 27% 8 27% 
Caesarean section (n=30) 8 27% 14 47% 8 27% 
Complications after delivery  
Reported complications after delivery (n=30) 6 20% 14 47% 10 33% 
Developmental milestones  
Gross motor milestones  within normal range 
(n=30) 
22 73% 8 27% - - 
Speech language development within normal 
range (n=30) 
15 50% 15 50% - - 
 
As indicated in table 3.2.  
Eight (27%) caregivers could not report on the pregnancy and 10 (33%) could not report on 
the health of the pregnancy due to the following reasons: 
 The mother of the child was deceased and the caregivers  were not present in the early 
stages of development. 
 The child was accompanied by another relative and the mother was not available 
during the case history interview. The relative did not have knowledge of the case 
history information. 
 Due to family background, the mother did not reside with the caregiver during the 
pregnancy and hence the relatives do not have the information. 
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In addition the majority of  22 (73%) of the children were reported to present with normal 
gross motor development and 15 (50%) were reported to present with delays in speech-
language developmental milestones. 
3.4.7. Medical history  
Table 3.3., describes the co-existing medical conditions. 
Table 3.3.  




TB  11 36% 
Seizure 2 6% 
Encephalopathy 1 3% 
Total 14 46% 
 
Fourteen (46%) participants had other co-existing medical conditions, i.e. 11 (36%) 
participants had TB, 1 (3%) had encephalopathy and 2 (6%) had seizures. 
 
3.4.8.Scholastic history 
Scholastic history was obtained from the participants in relation to grades as indicated in 






Table 3.4.  
Grades of the participants 
Grade N=30 
 Number Percentage 
R 2 6.7% 
1 4 13% 
2 7 23% 
3 4 13% 
4 6 20% 
5 4 13% 
6 2 6.7% 
7 1 3.3% 
 
The participants’ academic performance is highlighted in Figure 3.1. 
 
Figure 3.1: Reported academic performance of children 
 
As described in figure 3.1., fourteen (47%) of the caregivers reported that the child has 
repeated a grade, while 16 (53%) had fifteen participants (50%) reported that the child was 
not coping currently academically while 15 (50%) reported that the child was coping 







































3.4.8. Antiretroviral treatment regimen  
Figure 3.2, highlights the percentage of participants on each of the ARV regimens.  
 
Figure 3.2: Antiretroviral regimen number 
 
Twenty nine participants (97%) were on ARV and one participant (3%) was ARV naive at 
the time of testing as his viral load was below detectable levels  most of the participants  21 
(72%) were on regimen two while 8 participants (27%) were on regimen one, which are listed 
in chapter 2 section 2.5. Twenty four (82%) participants had been on ARV longer than five 
years and 6 (20%) participants  have been on ARV less than five years, while one (3%) 
participant was ARV naive at the time of testing as his viral load was below detectable levels. 
 
 
3.5.  Data Collection Procedures 
The following data collection process was followed: 
 Ethical clearance to conduct the study was obtained from the University of KwaZulu-









 Authorisation to conduct the study at King Edward VIII hospital was obtained from 
the KwaZulu-Natal Department of Health (DOH) Research Ethics Committee (See 
Appendix B), and from the King Edward VIII Chief Executive Officer (CEO) (See 
Appendix C). 
 The researcher liaised with health professionals (i.e. nurses and doctors) from the 
King Edward VIII Philani ARV clinic to make them aware of the study (See 
Appendix D) to facilitate recruitment of participants. 
 The caregivers were given a letter that explained the study details in English (See 
Appendix E1) and isiZulu (See Appendix E2). Consent was obtained from the 
caregiver to participate in the study using a consent letter with a form for the care 
giver to sign in English (See Appendix F1) and isiZulu (See Appendix F2). The child 
had to provide assent and write their name on the form to indicate voluntary. 
participation. The form was available in the English (See Appendix F3) and in IsiZulu 
languages (See Appendix F4). 
 A case history interview was conducted with the caregiver to obtain case history 
information in English (See Appendix G1) or IsiZulu (See Appendix G2). 
 The researcher conducted a medical history review using a medical record form (See 
Appendix H). 
 Audiological procedures followed the typical order of testing in a clinical setting:  
o Otoscopic examination. 
o Immittance audiometry. 
o Distortion product Otoacoustic emissions (OAE) testing. 
o Pure tone audiometry i.e. air and bone conduction. 
o Speech audiometry i.e. Speech Reception Thresholds (SRT) and Speech 
Discrimination (SD) testing. 
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o Auditory Brainstem Response testing. 
 The caregiver and participant were given feedback of the audiological results. 
Participants were given the opportunity to ask questions related to the results.  
 If abnormalities were observed during the assessment, referrals were made  for the 
necessary follow up at the relevant departments. 
 Information pamphlets regarding hearing loss in English (See Appendix I1) and 
IsiZulu (See Appendix I2) were given to patients after completing the audiological 
testing (See Appendix I). 
 At the end of the session, the child and the caregiver were given light refreshments, 
and the caregiver was given R50 for travel as a  token of appreciation.  
 
3.6. Data collection method 
A description of the data collection procedure, motivation for its inclusion, the data collection 
tool and the equipment is highlighted in Table 3.5. 
 
Table 3.5. 
 Data collection procedure, motivation for procedure, and equipment used 
Procedure Motivation for inclusion: Tool & procedure: Equipment 
1. Biographical 
information 
Age, gender, and ethnic group was recorded for 
statistical purposes 
Case history questionnaire (See 
Appendix G1 & G2). 
N/A 
2. Case History 
information  
A case history questionnaire was developed for this 
study. The questionnaire had 26 questions, 10 closed 
ended and 16 open ended questions to provide 
elaborations on the response.  The case history 
consisted of questions to obtain information relating 
to the following areas: 
 Pregnancy and birth information 
 Developmental history 
 Medical history 
A case history questionnaire 
(See Appendix G1 in English 
and G2 in isiZulu). An 
interview was conducted with 




 Hearing related problems 
 Educational history such as scholastic 
performance 
 Reported hearing difficulty 
 Medical intervention received 
 Other pertinent information relating to 
hearing loss.  
3. A medical 
record form 
A medical record form was developed for the purpose 
of this study. It consisted of 3 sections that used a 
checklist to capture the required information. 
Information on the following pertinent information 
was recorded: 
 CD4 cell  measures within 6 month period 
 Viral load measures within 6 months 
 ARV regimen was recorded for those who 
had commenced ARV. 
 Other prescribed drugs for other medically 
related conditions 
 Audiological intervention which included 
audiological tests administered, results and 
management strategies employed to manage 
the presenting audiological condition. 
This provided information on medical factors that 
could have an impact on the results of the study and 
the researcher aimed to identify ARV drugs used to 
combat opportunistic infections affecting the auditory 
system. 
Medical record review forms 
(See Appendix H), was 
developed by the researcher, 






An otoscopic examination was conducted using a 
checklist. The otoscopic examination aimed to 
provide a detailed description of the external auditory 
canal to report any abnormalities and foreign bodies. 
In addition, the otoscopic examination  allowed the 
researcher to report on the status of the external ear, to 
identify signs of outer and/or middle ear disease, and 
to ensure that no contraindications exist for 
performing tympanometry and Otoacoustic emissions 
(OAE) e.g. discharge, foreign bodies,  and 
tympanostomy tubes as directed  by ASHA (1997).  
 An otoscopic examination 
checklist, developed for the 
purpose of the study was 
used to interpret the 
findings.  
 The results were recorded 
on the checklist (See 
Appendix J). 
Wall mounted Welch 
Allyn diagnostic 
otoscope 
5. Immittance Tympanometry was used to assess middle ear  Results from Immittance Interacoustic AZ 26 
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audiometry function (Nozza, Bluestone, Kardatzke & Bachman, 
1994). Tympanometry is a standard method used to 
detect middle ear pathology, and is normally 
conducted using a 226 Hz probe and 85dBSPLs 
(Koivunen et al., 2000). The Jerger classification 
system was used Jerger, 1970 as cited in Gelfand 
(2001). Tympanograms were classified as Type A, 
Type As, Type Ad, Type C and Type B. Further the 
normative values specific to the GSI Tympstar and 
Interacoustic AZ 26 (diagnostic) middle ear analyzer 
were used.  
 
Ipsilateral acoustic reflex testing provided information 
related to the function of the conductive and the 
sensory pathway, and contra lateral reflex thresholds 
provide information regarding the neural and motor 
pathway associated with the “reflex arc” (Palmu, 
Puhakka, Rahko, Takala, & Kilpi, 2002). Acoustic 
reflex thresholds test is an acoustic test based on the 
direct recording of acoustic impendence of the middle 
ear (Weatherby & Barnet, 1980).  
audiometry were recorded 
on the form designed by 
the researcher (See 
Appendix K1- Record 
form). 
 Immittance audiometry 
was conducted as per the 
procedure outlined in 
appendix K2.  
 The results were 
interpreted using normative 
data(See Appendix K3- 
Normative data). 
middle ear analyzer 








OAEs are predicted to be the by-product of the pre-
neural mechanism of the cochlea amplifier and in 
particular they are linked to the normal functioning of 
the outer hair cells; thereby making them sensitive to 
hearing loss caused by outer hair cell damage 
(Koivunen et al., 2000). OAE can detect cochlea 
dysfunction before it is evident in pure tone 
audiometry, making these results crucial for detecting 
onset of cochlea dysfunction associated with 
ototoxicity. OAEs were used as an objective measure, 
as part of the audiological test battery for detecting 
outer hair cell damage as a possible indicator of 
ototoxicity (Marshall, Lynne, Heller, Laurie, & 
Westhusin, 1997). OAE may be absent if there is a 
middle ear pathology (Lehmann et al., 2008). 
According to Marshall et al., (1997), OAEs are very 
susceptible to middle ear variation, since the negative 
pressure affects the delivery of the stimulus through 
the, middle ear to the cochlea (Marshall et al., 1997). 
 DPOAE were recorded on 
the form designed for the 
purpose of this study (See 
Appendix K1- Record 
form) and interpreted as 







OAEs provide information about the integrity of the 
auditory system up to the cochlea (DeBonis & 
Donohue, 2008). OAEs are thought to be a more 
objective physiological measure. A diagnostic 
DPOAE protocol was used in the study.  
7. Pure tone 
Audiometry 
Pure tone audiometry aimed to provide a distinction 
between normal hearing and abnormal hearing by 
describing the results in terms of degree, type, 
configuration and nature of hearing sensitivity 
(Gelfand, 2001). The frequency range was from 
250Hz to 8000Hz via air conduction. Bone 
conduction testing was conducted from 250Hz to 
4000Hz frequencies (Ahmad & Pahor, 2002).  
A pure tone signal was presented via TDH 49 
headsets in a sound proof audiometric booth (Hall & 
Swanepoel 2010). 
 Pure tone audiometry was 
conducted as per the 
procedure outlined in 
Appendix L1 
 The Results were 
documented on an 
audiogram (See Appendix 
L- Audiogram) 
 Results were interpreted as 
per normative data 
presented in Appendix L1- 
Normative data) 
Interacoustic AC 30 
Or Madesen 










Speech audiometry was used to assess speech 
comprehension as part of communication, and was 
also used as a site of lesion test as an indicator of 
language comprehension development, making it 
essential that words used in the test be familiar and 
linguistically appropriate (Ramkisson, 2000). Speech 
audiometry is a crucial aspect to the diagnostic 
audiometry, as it provides information on linguistic 
abilities but can also be used for correlating 
immittance and pure tone findings (North & Downs 
2002). Speech Reception Thresholds (SRT) was used 
to correlate and confirm reliability of the pure tone 
audiometry (Gelfand, 2001).   Live speech testing was 







Speech Discrimination Testing (SD) PI-PB Function 
was used to determine the lesion site. The isiZulu 
discrimination word list developed by Balkisoon, 
 The results were documented 
on the audiogram (See 
Appendix L- Audiogram) 
 Speech audiometry was 
conducted as per the 
procedures outlined in 
Appendix M1 
 The normative data for 
interpretation of the results is 
indicated in Appendix M2- 
Normative data). 
 The digit test, which has been 
proven to be reliable for non-
native English speakers, was 
used (Ramkisson, 2000) for 
Speech Reception testing for  
the IsiZulu speakers  (See 
Appendix M3) 
 
 IsiZulu speaking children 
were tested using the word 
list developed by Balkisoon, 
Sound proof 
audiological testing 
booth (double suit). 
Interacoustic AC 30 
Or Madesen 




(2001) was used to establish the PI-PB function for 
isiZulu speaking children. While this has undergone 
formal development through research methods, its 
validation has not been formalised. Speech 
Discrimination was obtained using live speech testing. 
In this study, pure tones and speech audiometry was 
used to correlate immittance results using the cross 
check principle (Matas  etal., 2010). Speech 
audiometry provided means for the researcher to 
understand the impact of hearing loss on 
communication (Hall & Swanepoel, 2010).  
(2001) for establishing the 
SD PI-PB function  (See 






ABR is not a hearing test but is a measure of 
synchronized nerve firing along the auditory 
brainstem pathways in response to auditory stimuli 
(Bachman & Hall, 1998). It can be used to assess 
peripheral auditory sensitivity. ABR is essentially 
unaffected by the state of consciousness and 
responses can be recorded at or near auditory 
threshold (Bachmann & Hall, 1998; Hurley, Hurley & 
Berlin, 2005). ABR was used as a site of lesion test to 
distinguish between cochlear and retrocochlear 
pathology (Niskar et al., 1998).   
ABR was conducted as per 
procedure outlined in Appendix 
N.  
Data was analyzed using the 
normative data (See Appendix 
N2) for the procedure and 
normative data 




All equipment had undergone the necessary calibration (See Appendix O, O2, and O3) and 
biologic calibration was carried out daily by the researcher to ensure the equipment was 
functioning. 
 
3.7. Pilot study 
A pilot study was conducted to establish whether the questions were clear and to identify 
ambiguity in the case history questionnaire. The pilot study aimed to assess the rate, ease of 
recruiting participants and the time to conduct a full audiological test on each participant 
(Babbie, 2008, Gravett & Foronzo, 2009). The recommendations from the participants of the 
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pilot study were used to guide the data collection process (Shi, 2008). The aims, outcomes 
and recommendations obtained from the pilot study are discussed in Table 3.5. 
 
Table 3.6 
 Purpose, procedures, outcomes and recommendations from the pilot study 
Purpose Procedures Outcomes Recommendations 
1. To determine the time 
taken to complete the case 
history interview 
A case history interview was 
conducted and the time taken 
was noted. 
The average time to conduct the 
case history was 5 minutes. 
To retain the questionnaire and 
no amendments were required. 
2. To determine the clarity of 
the questions asked during 
the case history interview 
A case history interview was 
conducted using predetermined 
questions on five participants 
not included in the main study. 
This was done to determine if 
the questions were ambiguous 
or difficult for the participants 
to understand. 
The questions were clear and 
easy to understand. The order of 
the questions was sequential and 
logical. 
No amendments were required. 
3. To determine the time 
taken to conduct a 
complete audiological 
assessment on one patient 
A complete audiological 
assessment was conducted and 
the time taken was noted. 
The average time to complete 
the audiological test battery was 
1hour 45minutes. 
The researcher to maintain the 
same time to speed up the data 
collection process to meet the 
target population. The order of 
testing had to be maintained. 
4. To determine efficiency of 
the recruitment process 
from the ARV clinic to the 
Audiology department  
A recruitment process was 
commenced with five 
participants. Time, efficiency 
and accessibility were noted. 
The best way to recruit the 
participant was for the 
researcher to physically go to 
the clinic and address the 
participants in the waiting area 
and provide a brief explanation 
of the study. This made the 
participants willing to attend 
when referred by the medical 
staff as they were familiar with 
the study and the inclusion 
criteria. The best time was 
between 7.30-8.30 am. 






3.8. Infection control 
Infection control standards, as stipulated by Infection Control for Regulated Professionals 
(Browne, Gignac, Hamilton, Harrison, Hunter, James et al., 2007; Burco, 2007) were 
maintained (See Appendix P). Infection precautions included patient contact and 
environmental hygiene, which consisted of using latex gloves during handling the patient and 
instruments used for the patients. All specula, probe nubs and electrodes were disinfected 
after each patient to prevent infection transmission. 
 
3.9. Ethical and legal considerations 
The current study followed the guidline provided by the World Medical Association (2008) 
Helsinki Declaration.  
The research protocol was submitted for guidance and comment to the University of 
KwaZulu-Natal Biomedical Ethics Committee prior to commencing the study (See Appendix 
A). Authorisation to conduct the study at King Edward VIII hospital was obtained from the 
KZN Department of Health Research Ethics Committee (See Appendix B), and from the 
King Edward VIII Chief Executive Officer (CEO) (See Appendix C). The researcher liaised 
with health professionals (i.e. nurses and doctors) from the King Edward VIII Philani ARV 
clinic (See Appendix D) to make them aware of the study to facilitate recruitment of 
participants.  
The following ethical and legal issues and considerations were addressed: 
 Permission from the gate keepers i.e. KwaZulu-Natal Biomedical Ethics Committee, 
King Edward VIII Hospital and KwaZulu-Natal Department of Health was obtained. 
 The primary researcher was a qualified Speech Language Therapist and Audiologist 
with appropriate qualifications to conduct the audiological procedures. 
56 
 
 The researcher ensured that all participants understood the requirements of the study 
and voluntary participation was ensured through the signing of a consent form 
(Newman, Browner, Cummings & Hulley, 2007). The child’s legal guardian had to 
provide consent. In the event of child headed households, the eldest child or relative 
who served as the guardian of the younger sibling had to provide consent. If the 
participants were English second language speakers, the researcher explained in 
isiZulu, as the researcher was fully competent in both languages. Informed assent was 
obtained from the child, as they are cognitively able to agree or disagree to 
participate. (Greig et al. (2007, p. 172) recommend that “informed consent from the 
child’s legal guardian should be obtained and in addition the child’s assent should 
also be sought. Even though a child may not be legally competent to give consent, 
researchers should gain informed assent”(Greig et al., 2007, p. 174). The child’s 
caregiver was present with the child during testing. For illiterate caregivers, the 
consent was obtained verbally, and thumb prints were obtained to indicate voluntary 
consent to participate. Signed copies were kept with the audiological information in a 
folder, where the researcher is the only one who has access. 
 The participants were informed that they can withdraw from the study without any 
negative penalties (Simon & Burstein, 1985). This explanation was in the information 
document to the caregivers in English or isiZulu and the information was also 
provided verbally before commencing with the case history and audiological testing. 
 Confidentiality and anonymity was ensured by assigning numbers to participants 
instead of using names or hospital numbers which can reveal the identity of the 
participants. During the course of the study, the participants were identified by their 
numbers. The same numbers were used when the results were presented to research 
supervisors to maintain confidentiality of the participants.  On completion of the 
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study, the documentation and data will be kept in a locked cupboard at University of 
KwaZulu-Natal Audiology Department for five years and thereafter shredding will be 
used to dispose of the information (Maxwell & Satake, 1997). 
 All audiological results were explained to the participants in simple language that did 
not use jargon to make sure that they understood the implications of the audiological 
findings. Participants who required further audiological management or other medical 
intervention were referred to the relevant departments within the hospital. 
 Participants were informed that the procedures were not invasive and no harm was to 
come to them. Adhering to test procedures and use of non-invasive tests was ensured. 
Calibrated equipment was used to ensure patient safety (See Appendix O). 
Appropriate sterilisation and cleaning of instruments during testing were carried out 
(McMillan & Schumacher, 2001). 
 Information pamphlets relating to hearing loss and effects on language development 
were made available to all participants. The pamphlets are available in English ( 
Appendix I1) and isiZulu (Appendix I2). 
 The researcher has completed an accredited on line ethics course with the University 
of KwaZulu-Natal (See Appendix Q) to ensure that all research ethical principles 
were adhered to during the study. 
 
3.10.  Validity and reliability 
Validity refers to the extent to which a test measures what it is supposed to measure (Berg & 
Latin, 2004). In the current study, measures used (i.e. audiological tests such as immittance 
audiometry, OAE, pure tone audiometry, speech audiometry and ABR) have been proven to 
be valid and are in keeping with best practice methods in audiology (Gelfand, 2001).  
Immittance audiometry measures the middle ear status, while OAE assesses the integritiy of 
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the outer haircells in the cochlea and ABR measures neural integrity (Kazunari, 2006). 
Therefore all the afore mentioned audiological assessment tools are considered to be 
objective tests, and have undergone rigorous construct validity assessments (Shi, 2008; 
Swanepoel, 2007 ).  
A case history questionnaire and medical record form were developed for the purpose of the 
study to provide qualitative and quantitative audiological history.  These forms were devised 
after consulatation with literature on case history form development. The medical record 
form was designed to capture the immunological status, medical and audiological history as 
well as drug regimen details. To ensure construct validity, a pilot study was conducted on 
five participants to ensure that the questions were relevant, appropriate and provided the 
required data (Babbie, 2008).  In addition these measures were used to correlate the results, 
thus ensuring that the study tools have criterion validity (Leedy & Omrod, 2005).  
These tests assisted the researcher to achieve criterion based validity, where the audiological 
results were obtained using the acceptable standard of audiological practice (Babbie, 2008). 
The researcher ensured that all equipment used was in good working order, met the clinical 
requirement standards and had been calibrated to ensure that results obtained are valid and to 
obtain face validity (Leedy & Omrod, 2005). This process aimed to counter against internal 
validity threats (Gravette & Forzano, 2009). A statistician was consulted to analyse and 
interpret the results. Berg and Latin (2004) indicated that statistical validity is considered to 
be the strongest form of validity.  
 
Reliability measures the consistency of the test scores or data (Babbie, 2008). To ensure 
reliability, formal audiological tests were used. The selected test procedures, order of testing 
and interpretation of the results have been established to be reliable by literature. Short breaks 
between tests to enhance performance were included. While the audiologist calculated the 
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pure tone average, the participant was instructed to stand, stretch and to prepare for the next 
test. This provided a break and improved concentration to improve validity during testing 
(Gelfand 2001). 
The case history questionnaire, information pamphlet, and consent document have been 
translated into isiZulu and the method of back translation has been used to ensure accuracy of 
translated materials. The researcher translated the documents, while a first language isiZulu 
person assessed correct dialect, grammar, and spelling. A bilingual clinician conducted back 
translations of the documents. This ensured that all materials translated captured the content, 
and the linguistic structures, and to validate the initial translation (Maxwell & Satake, 1997). 
 
 The ABR was used as an objective test to assess neural integrity and as a site of lesion test to 
differentiate between cochlea and retrocochlea pathology (Gelfand, 2001). The ABR was 
considered an objective test, as the response originates from neural generators and the 
participant does not provide any behavioural responses (Bachmannn & Hall, 1998). However, 
result interpretations are subjective, which could result in reliability challenges (Janssen, 
2008). To ensure that ABR result interpretations were reliable, the researcher requested the 
assistance of an independent audiologist experienced in ABR testing to also interpret the 
result. This process was also known as interrater reliability  (Berg & Latin, 2004, Leedy & 
Omrod, 2005). In addition the researcher attended training on ABR to improve skills in test 
protocols and interpretation. The researcher underwent training on the appropriate use of the 
equipment from HASS Medical and Interacoustics Equipment suppliers to ensure reliable and 
accurate results were obtained. The researcher followed standard clinical practice in 
audiology for administering the audiological tests i.e. case history, otoscopy, immittance, 
OAE, pure tones, speech audiometry and ABR. This ensured that standardization is achieved 
by administering the test in a consistent manner. All the above mentioned factors aimed to 
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counter bias, and to meet the criteria for admissible and reliable data (Leedy & Omrod, 
2005). 
 
3.11. Data Management  
The researcher created a data base of all the participants, where detailed biographical 
information was recorded. Then each participant was allocated a number that was used for 
identification during the study. The hard copies of the data were stored in individual folders 
that were collated into one big folder that was stored at the Department of Audiology in 
UKZN in a locked cabinet for a period of 5 years, and then subsequently disposed of by 
shredding. The digital data was stored on a password protected computer, and the raw data 
was only made available to the researcher, supervisors and statistician.  The files will be 
deleted with the supervisor’s permission after five years. 
 
SPSS version 22 software was downloaded from the University of KwaZulu-Natal (UKZN) 
website for data analysis. The researcher then consulted a statistician, Mrs. Fikile Nkwanyana 
from UKZN to advise with undertaking the analysis.  
 
3.12. Data Analysis 
 Questionnaire 
The biographical data, pregnancy and birth information, developmental history 
educational history inclusive of academic performance, hearing related problem, reported 
hearing difficulty and medical intervention were analysed using descriptive statistics 
(number and percentage), and were presented in tables. The researcher attempted to draw 
associations between reported hearing related problems and hearing status through cross 
tabulation of immune classification and hearing status. Cross tabulation is sub-type of 
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descriptive statistics that is used for determining association between nominal variables 
(Gradey & Heast, 2007). The  level of significance was set at p < 0.05 for inferential 
statistics. 
 
 Medical history 
The medical records were reviewed to gain information about the participant’s HIV 
status and medication, the use of drugs for opportunistic infections, and any audiological 
diagnosis and interventions provided. The data was analysed using descriptive statistics 
such as proportions, and the results were presented in tables. The researcher attempted 
to determine if there is a relationship between hearing status and medical status in terms 
of CD4 count and viral load. This was achieved with the use of the Chi-square test for 
correlation  (Gravett & Foronzo, 2009). Chi-square is a statistical test which, forms part 
of the non-parametric tests, used for establishing significant difference between the 
frequency of observed and expected observations or variables (Berg & Latin, 2004). 
 
 
 Audiological procedures 
The data from the audiological tests were analysed to identify the occurrence of hearing 
loss type, degree, configuration and symmetry.   
 
1) Otoscopic examination results were presented using descriptive statistics i.e. frequencies 
and percentages and were presented in tables. 
2) Immittance audiometry results were classified as follows:  
a)  Tympanometry results were first classified according to Jerger & Jerger’s (1970) as 
cited in Gelfand (2001) classification, which indicated the four types (Appendix K3).  
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These were further analysed using descriptive statistics such as frequencies and 
percentages and were presented in tables. In addition the Chi-square test  was used to 
compare tympanometry results and CD4+ T Lymphocyte categories. 
b) Acoustic reflex thresholds were classified as absent, elevated or present (See 
Appendix K3). These were further analysed using descriptive statistics such as 
frequencies and percentages and presented in table form. The independent T test was 
used for correlation between immunological status and acoustic reflex results (Leedy 
& Omrod, 2005). The t- test is a correlation test used to compare means of two groups 
to establish significance and to assess if scores are related. In addition, this test can be 
used to compare two related groups (Berg & Latin, 2004). 
 
3) Pure tone audiometry results were first classified according to hearing loss type as 
described in Table 3.6. Pure tone results were also used to classify hearing loss degree 
and configuration (Appendix K3). These were further analysed using descriptive statistics 
such frequencies and percentages and presented in bar graphs.  Association between 
hearing status and immunological status was determined through cross tabulation where 
two variables were compared. The Pearson’s correlation test and the Independent T- test 
were used to determine correlation between immunological status using CD4+T 
lymphocyte, hearing loss type and degree of hearing loss. Hearing loss symmetry and 
laterality was reported in frequencies and percentages. The Pearson’s correlation test is a 
non-parametric statistical analysis for assessing a relationship between two variables 






4) Speech audiometry: 
a)  Speech Reception Threshold was used to indicate reliability of the pure tone 
audiometry results, and was categorised as good, fair or poor based on the PTA/SRT 
correlation. The correlation was used to rate the audiograms reliability.  
b)  Speech Discrimination test results were classified (Appendix M) according to  the 
normative data. 
c) Descriptive statistics such as frequencies and percentages were used and the results 
presented in tables. 
 
5) Otoacoustic Emissions (OAE): A response was considered present when the DP 
amplitude level was equal to or greater than 6dB above the noise floor. The DPOAE was 
expected to be present with pure tone thresholds better than 25dB HL and was absent for 
hearing losses greater than 40dB (Gelfand, 2001).  Descriptive statistics such as 
frequencies and percentages was used and the results presented in tables. The Spearman’s 
correlation test was used to determine if a significant correlation exists between 
immunological classification using CD4+T lymphocyte count, viral load and DPOAE 
results was carried out. The Spearman’s test is similar to the Pearson’s correlation test, 
which is classified as a non-parametric statistical analysis for assessing a relationship 
between two variables (Berg & Latin, 2004). 
 
6) ABR: A neurological ABR was used in this study to assess neural integrity. Matas et al., 
(2010) recommend that the results be classified as Lower brainstem (LB) and Higher 
brainstem (HB) to provide a site of lesion distinction along the auditory pathway based on 
absolute latancy results and interpeak results.These results were presented in a table and 
the Spearman’s correlation test was carried out to determine the significance of the 
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correlation between immunological status and ABR results. The descriptive classification 
of hearing loss used in the study, is described in Table 3.7. 
 
 
Table 3.7.  
Classification of hearing loss  
Type of hearing 
loss 




-Type As, Ad, C, and 
B tympanograms 
-Elevated or absent 
acoustic reflex 
thresholds 
-Air Bone Gap (ABG) 
between Air 





PB Max of 100% 
achieved at higher 
intensity levels for  PI-
BP function  
Absent emissions Increase of 
electrophysiological 
thresholds; delay in 
absolute latencies of 
waves I, III and V; and 
normal interpeak I-III, III-






-Present or absent 
acoustic reflex 
thresholds 
-No ABG between 
AC and BC 
-Depressed AC and 
BC thresholds 
Cochlear  
May reach PB Max of   
100% or a dynamic 
range of <45dB suggest 
recruitment. 
Roll over ratio <0.45 
Retrocochlear 
-Difficulty with 
attaining  PB Max of 
100% discrimination 
with roll over >20% and  
the 
-PI-BP function roll 
over ratio >0.45  
Cochlear  
Emissions may not  
be present at affected 
frequency ranges or 
will be reduced 
 
Retrocochlear 
Clear emissions may 
be recorded and 
within normal range 
Note: Absent 




threshold and absolute 
latencies of waves I, III 
and V; and normal 
interpeak I-III, IV and V 
at high intensity 
Mixed hearing 
loss 
-Type As, Ad, C, and 
B tympanograms  










Absent emissions due 
to middle ear status 
-Absolute latencies will 
be delayed. 
-Normal interpeak at 
elevated levels.   
-Wave V will be detected 







HIV status and hearing loss 
The researcher attempted to draw inferences  between case history findings and hearing status 
through correlation statistics such as Spearman’s correlation test. Correlation was determined 
between hearing status and medical status, in terms of CD4 count and viral load, and 
treatment. This was done by using statistical tests such as Chi-squared test for correlation 




The current study utilised  an exploratory   non-experimental, non-probability convenient 
sampling technique to meet the objectives and aim of the study. Strict inclusion and exclusion 
criteria were stipulated and the data collection procedure was described in detail. The 
researcher established that case history, otoscopic examination, immittance audiometry, pure 
tone audiometry, speech audiometry, OAE and ABR test procedures constitute the best 
audiological practice to reach the aims and objectives of the study. Ethical and legal 
considerations were discussed in detail and the researcher highlighted reliability and validity 
issues associated with this study. Finally, the study described statistical measures used to 










CHAPTER 4: RESULTS 
4.1. Introduction 
This chapter describes the results using descriptive statistics from SPPS version 22 statistical 
software package. The results are presented with reference to the objectives of the study. 
Audiological results will be described and inferential statistics will be used to find 
associations between hearing results and CD4 cell count. In addition, an overall audiological 
profile of hearing loss will be described using the audiological test results. A summary of 
relevant case history information focusing on reported hearing impairments and other co-
existing medical conditions will be provided in this chapter in relation to the objectives of the 
chapter. Finally, a report will be given in relation to audiological and medical intervention 
received by the participants as indicated in the medical records. 
 
4.2. Audiological profiling 
The first objective of the study was to describe the prevalence and nature of hearing loss in 
terms of degree, type, configuration and symmetry of any hearing loss observed. 
Audiological profiling was achieved using the audiological test battery approach.  A cross 
check principle was used to interpret the hearing test resultsA detailed spread sheet of the 
individual test result is presented in Appendix S.  
4.2.1 Otoscopic examination 






Table 4.1.  
Otoscopic examination results 
Observation Right ear n=30 Left ear n=30 
 Number  Percentage Number Percentage 
Overall otoscopic results 
Normal results 13 43% 11 37% 
Abnormal results 17 57% 19 63% 
Total 30 100% 30 100% 
Abnormal otoscopic results 
Stenosis of canal 1 6% 1 6% 
Discharge 2 12% 2 12% 




4 24% 5 29% 
Retracted tympanic 
membranes 
6 35% 5 29% 
Bulging tympanic 
membranes 
2 12% 1 6% 
 
Normal otoscopic findings were observed in the right ear of 13 (43%) participants, and the 
left ear of 11 (37%) participants. Abnormal otoscopic findings were observed in the right ear 
of 17 (57%) participants, which was more than half of the sample, and the left ear of 19 
(63%) participants.  The description for the  presence of wax was inclusive of occlusive and 
impacted wax. Middle ear pathology was observed in 18 (60%) of the participants based on  
abnormal otoscopic findings  indicative of middl ear pathology.  In addition, middle ear 
dysfunction  was confirmed by use of immittance audiometry results, which are described in 
detail in the next section. 
 
4.2.2. Immittance results 
4.2.2.1. Tympanometry 




Table 4.2  
Tympanometry results 
Immittance  Right ear n=30 Left ear n=30 
 Number  Percentage Number Percentage 
Tympanometry     
Type A 17 57% 18 60% 
Type B 2 6% 3 10% 
Type C 5 17% 3 10% 
Type As - - - - 
Type Ad 1 3% - - 
Could not test 5 17% 6 20% 
TOTAL 30 100% 30 100% 
 
It is evident from Table 4.2, that   17 (57%) of the  right ear tympanograms were normal type 
A, while 8 (27%) were abnormal. Eighteen,  (60%) of the left ear tympanograms were normal 
type A, while 6 (20%) were abnormal. The right ears of 5 (17%) participants  and left ear of  
6 (20%) participants could not be tested due to fluid in the ear canal and perforated tympanic 
membranes.  A prevalence of 12 (40%) participant presented with middle ear pathology. 
Further analysis was carried out using the Chi-square test, a p value of 0.4 was obtained, 
indicating that there is no significant correlation (p≤ 0.05) between the CD4+T Lymphocyte 
measures and tympanometry.  
 
4.2.2.2. Acoustic reflex threshold testing 





Acoustic reflex testing results 
Immittance  Right ear n=30 Left ear n=30 
 Number  Percentage Number Percentage 
Ipsilateral 
Normal 17 57% 18 60% 
Abnormal 8 27% 7 24% 
Could not test 5 16% 5 16% 
TOTAL 30 100% 30 100% 
Contra lateral 
Normal 12 40% 13 44% 
Abnormal 13 44% 12 40% 
Could not test 5 16% 5 16% 
TOTAL 30 100% 30 100% 
 
Abnormal ipsilateral acoustic reflex thresholds were observed in the right ear of 8 (27%) 
participants and the left ear of 7 (24%) participants  Abnormal contra lateral acoustic reflex 
results were obtained in the right ear of 13 (44%) participants and the left ear of 12 (40%) 
participants. The independent sample test revealed a p value of 0.48, indicating that there was 
no significant correlation (p≤ 0.05)  between immunological status and acoustic reflex 
thresholds.  
 
4.2.3. Pure tone audiometry 
The following results will describe the prevalence and  nature of hearing loss in terms of 
degree, type, configuration and symmetry. Twenty eight participants contributed data for the 
pure tone audiometry, as two participants could not be conditioned to perform the test.  
 
4.2.3.1. Degree of hearing loss 




Figure 4.1:  Degree of hearing loss  
Of the 28 participants assessed, 13 (46 %) presented with normal hearing in the right ear and 
15 (54 %) presented with normal hearing in the left ear. Thus hearing loss was observed in 
right ear of 15 (54%) participants and in the left ear of 13 (46%) participants. Mild hearing 
loss was the most common with a small percentage of moderate to severe hearing loss. 
 
4.2.3.2. Type of Hearing loss  










Normal Mild Moderate Moderate-
Severe
Severe
Left ear 15 8 4 0 1






























Figure 4.2: Type of  hearing loss 
Of the 28 participants assessed, conductive hearing loss was the most common, followed by 
sensorineural hearing loss  and mixed hearing loss.  
 
4.2.3.3. Configuration of hearing loss 
It must be noted that the right ear had 15 (54%) hearing loss and the left ear presented with 
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Figure 4.3: Configuration of hearing loss 
Figure 4.3 above, illustrates that  rising configuration was the most common configuration 
observed, seen in   the right ear of 6 (40%) participants and the left ear of 7 participants 
(53%). A rising audiological pattern is reported to be common configuration associated with 
conductive hearing loss in this sample . 
 
4.2.3.4..Hearing loss laterality 
Of the 28 participants who underwent pure tone audiometry, 12 (43%) had normal hearing 
thresholds bilaterally. Sixteen (57%) presented with a hearing loss in either one or both of 
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Figure 4.4.  Hearing loss laterality  
Of the 16  (57%) participants with a hearing loss four (25%) participants presented with 
unilateral hearing loss while the majority of 12 (75%) participants presented with bilateral 
hearing loss, as depicted by figure 4.4.   
4.2.3.5. Hearing loss symmetry 
Table 4.4. describes the hearing loss symmetry results. 
 
Table 4.4.  




Symmetrical 6 50% 
Asymmetrical 6 50% 




Of the 12 participants with a bilateral hearing loss half of the participants 6 (50%) presented 
with symmetrical hearing loss while the remaining 6 (50%) participants presented with 
asymmetrical hearing.  
 
The Independent T-test revealed a p value of 0.676 indicating that that there was no 
significant correlation between the CD4+ T-Lymphocyte classifications and degree of 
hearing loss. However, the Pearson’s correlation coefficient value of 0.01 for the two tailed 
test was obtained indicating significant correlation between hearing loss type, hearing loss 
degree with viral load and CD4+ T-Lymphocyte classifications (See Appendix S Table 1-4). 
Therefore, one can conclude that there is a relationship between hearing loss degree and viral 
load levels. 
 
4.2.4. Speech audiometry 
4.2.4.1. Use of Speech reception threshold to determine pure tone reliability 
Pure tone audiometry test reliability was established using the Pure Tone Average (PTA) and 
correlating it with Speech Reception Threshold (SRT) thresholds. Below in Table 4.5 is the 
detailed description of the pure tone audiometry test reliability results. Speech audiometry 
was conducted on 28 participants, as two participants could not be conditioned. 
Table 4.5.  
Pure Tone Average (PTA) Speech Reception Threshold (SRT) correlation 
PTA/SRT 
Correlation 
Right ear N=28 Left ear N=28 
 Number  Percentage Number Percentage 
Good 23 82% 25 89% 
Fair 2 7% - - 
Poor 3 11% 3 11% 




Good SRT-PTA correlation was obtained in the right ear of 23 (82%) participants, and in the 
left ear of 25 (89%) participants as indicated in Table 4.5, which is majority of the 
participants. Fair correlation was obtained in the right ear of 2 (7%) participants. Poor 
correlation was obtained 3 (11%) participants for both the ears.  From the speech audiometry 
results it is evident that the majority of the participants obtained good SRT/PTA correlation 
    
4.2.4. 2. Speech Discrimination testing 
Speech discrimination testing was conducted in 28 participants as two participants could not 
be tested since they could not be conditioned. Speech discrimination results are presented in 
table 4.6. 
Table 4.6.  
Speech Discrimination Test (SDT) results 




Number Percentage Number Percentage 
90-100 27 96% 27 96% 
89-75 - - - - 
74-60 - - - - 
60-50 - - - - 
<50 1 4% 1 4% 
TOTAL 28 100% 28 100% 
 
Speech Discrimination scores of 90 to 100% were obtained in the right ear of 27 (96%) 
participants bilaterally, while scores of less than 50% was obtained bilaterally for one (4%) 
participant.  Roll over was not observed in any of the results. These results correlated with the 
pure tone audiometry, where good discrimination scores are anticipated with conductive 
pathology. Therefore, the majority of the participants presented with good speech 
discrimination results with only 1 (4%) participant presenting with poor speech 
discrimination results suggestive of cochlear or retrochochlear pathology.  
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4.2. 5. Otoacoustic Emissions 
Distortion Product (DPOE) results are presented in table 4.7 below. 
Table 4.7  
DPOAE results 
Otoacoustic Emission Right ear n=30 Left ear n=30 
 Number  Percentage Number Percentage 
Pass 15 50% 12 40% 
Refer 3 10% 5 17% 
Could not test 12 40% 13 43% 
TOTAL 30 100% 30 100% 
     
 
Distortion Product Otoacoustic Emissions (DPOAEs) were not conducted in right ear of 12 
(40%) participants and the left ear of 13 (43%) participants due to the presences of outer and 
middle ear pathology. Only 18 (60%) participants underwent DPOAE testing in the right ear 
and 17(57%) in the left ear.  Pass results were obtained in the right ear of 15 (50%) 
participants and the left ear of 12 (40%) participants, while refer results were obtained in the 
right ear of 3 (10%) participants and in the left ear of 5 (17%) participants. Refer DPOE 
result indicate cochlear pathology, was in the range from 3 (10%) and maximum of 5 (17%) 
participants, supporting pure tone findings that sensorineural hearing loss was the least.  
Further analysis using the Spearman correlation coefficient revealed a p value of 0.037 for 
both ears, indicating a significant correlation between CD4+T-Lymphocyte classification, 
viral load and DPOAE results. Therefore, based on the results it appears that DPOAE has a 
relation with immunological status stage. 
4.2. 6. Auditory Brainstem Response (ABR)Testing 
Neurological ABR was conducted on 30 participants, resulting in 60 ears being tested. 
4.2.6.1. Absolute latencies  
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Table 4.8. below reports on the ABR absolute latency results. 
 
 
Table 4.8.  
 
Absolute latency results  
 
 ABR Absolute 
latency 
Right ear N=30 Left ear N=30 
Absolute latency I Number  Percentage Number Percentage 
Normal 20 67% 15 50% 
Early 2 7% 3 10% 
Delayed 4 13% 7 23% 
Absent 4 13% 5 17% 
TOTAL 30 100% 30 100 
     
Absolute latency III     
Normal 20 67% 14 46% 
Early 4 13% 2 7% 
Delayed 2 7% 9 30% 
Absent 4 13% 5 17% 
TOTAL 30 100% 30 100% 
Absolute latency V     
Normal 20 67% 16 53% 
Early 5 17% 2 7% 
Delayed  1 3% 7 23% 
Absent 4 13% 5 17% 
TOTAL 30 100% 30 100% 
 
The overview of absolute latencies results revealed that at least half of the participants 
presented with normal absolute latencies. The absolute latency of wave I was normal in the 
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right ear of 20 (67%) participants and the left ear of 15 (50%) participants; however, it was 
early in the right ear of 2 (7%) participants and the left ear of 3 (10%) participants. The 
absolute latency of wave I was delayed in the right ear of 4 (13%) participants and the left ear 
of 7 (23%) participants; whilst it was absent in the right ear of 4 (13%) participants and the 
left ear of 5 (17%) participants. 
 
The absolute latency of wave III was normal in the right ear of 20 (67%) participants and the 
left ear of 14 (46%) participants; however, it was early in the right ear of 4 (13%) participants 
and the left ear 2 (7%) participants. The absolute latency of wave III was delayed in the right 
ear of 2 (7%) participants and the left ear of 9 (30%) participants; whilst it was absent in the 
right ear of 4 (13%) participants and the left ear of 5 (17%) participants.  
 
The absolute latency of wave V was normal in the right ear of 20 (67%) participants and the 
left ear of 16 (53%) participants; however, it was early in the right ear of 5 (17%) participants 
and the left ear of 2 (7%) participants. The absolute latency of wave V was delayed in the 
right ear of 1 (3%) participant and the left ear of 7 (23%) participants; whilst it was absent in 
the right ear of 4 (13%) participants and the left ear of 5(17%) participants. Thus most of the 
results, close to half of the study population reflected normal results.  
 
4.2.6.2. Interpeak latencies of wave’s I-III, I-V, and III-V 






Table 4.9  
Interpeak latencies of wave I-III, III-V and I-V 
Inter-peak latency I-
III 
Right ear n=30 Left ear n=30 
Normal 19 64% 16 53% 
Early 6 20% 6 20% 
Delayed  1 3% 3 10% 
Absent 4 13% 5 17% 
TOTAL 30 100% 30 100% 
Interpeak latency III-
V 
    
Normal 18 61% 19 64% 
Early 4 13% 4 13% 
Delayed  4 13% 2 6% 
Absent 4 13% 5 17% 
TOTAL 30 100% 30 100% 
Interpeak latency I-V     
Normal 17 57% 16 53% 
Early 9 30% 6 20% 
Delayed  - - 3 10% 
Absent 4 13% 5 17% 
TOTAL 30 100% 30 100% 
 
Once again, normal results were obtained for both the left and the right ear for more than 
50% of the participants up to the range of 64% of the participants. The interpeak latency for 
waves I-III was normal in the right ear of 19 (64%) participants and the left ear of 16 (53%) 
participants; however, it was early in the right ear of 6 (20%) participants and the left ear 6 
(20%) participants. The interpeak latency of waves I-III was delayed in the right ear of 1 
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(3%) participant and the left ear of 3 (10%) participants; whilst it was absent in the right ear 
of 4 (13%) participants and the left ear of 5 (17%) participants.  
 
The interpeak latency for waves III-V was normal in the right ear of 18 (61%) participants 
and the left ear of 19 (64%) participants; however, it was early in the right ear of 4 (13%) 
participants and the left ear of 4 (13%) participants. The interpeak latency of waves III-V was 
delayed in the right ear of 4 (13%) participants and the left ear of 2 (6%) participants; whilst 
it was absent in the right ear of 4 (13%) participants and in the left ear of 5 (17%) 
participants. 
 The interpeak latency for wave’s I-V was normal in the right ear of 17 (57%) participants 
and the left ear of 16 (53%) participants; however, it was early in the right ear of 9 (30%) 
participants and the left ear of 6 (20%) participants. The interpeak latency of wave’s I-V was 
delayed in the left ear of 3 (10%) participants; whilst it was absent in the right ear of 4 (13%) 
participants and the left ear of 5 (17%) participants. 
Possible auditory dysfunction associated with the lower brain stem was observed in the right 
ear of 3 (10%) participants and the left ear of 4 (13%) participants. In addition, possible 
higher brainstem auditory dysfunction was observed in the right ear of 3 (10%) participants 
and the left ear of 3 (10%) participants. 
4.2.6.3. Inter-aural Latency differences 
Twenty six participants (87%) presented with inter aural latency differences of greater than 
0.5ms; while 4 participants (13%) presented with inter aural values of less than 0.5ms. Inter-
aural latency differences revealed that the ears were not symmetrical. The Spearman’s 
correlation p value of 0.20 was obtained indicating that there is no correlation exists between 
interpeak latencies and CD4+T-Lymphocyte classification. 
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4.3. Reported audiological and medical management received 
 
This section will report on objective two which was to determine whether children with a 
hearing loss have received medical management for their hearing loss and the nature of these 
interventions thus was achieve through a detailed case history. Case history of information 
reflecting pregnancy, medical history, hearing related history and medical intervention 
received, was obtained during the case history interview with the participants’ care givers. 
 
4.3.2. Hearing related history 
Figure 4.5., below describes the hearing related history. 
 
 
Figure 4.5:  Self reports relating to hearing history 
 
Thirteen (44%) participants caregivers reported hearing difficulties. Of those only 6 (26%) 
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the participants 24 (74%) did not have a hearing test prior the study even though hearing 
difficulty was reported. Seventeen (57%) participants had a history of ear infections. Of 
those, 15 (50%) participants reported that they had received medical attention for ear related 
problems. The caregivers of the participants reported that medical attention included 
antibiotics 5 (16%) ear drops from the clinics 1(3%), hospital medication 4 (13%), and 1 
(3%) over the counter treatment, whilst no treatment was sought or received by 1 (3%) 
participant. 
 
Figure 4.6. describes the otologic conditions reported. 
 
 Figure 4.6: Otologic conditions reported by participants  
Thirteen (43%) participants reported experiencing pain in the ears with ear infections and 
seven (23%) participants reported tinnitus. Two (7%) participants reported experiencing 
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correlation coefficient value of 0.01 was seen between recurrent chest infections and a 
predisposition to hearing loss due to middle ear pathology as observed in tympanometry 
results. A positive association was observed using cross tabulation, where participants that 
reported a positive history of middle ear infections had abnormal tympanometry results. This 
was observed, i.e. 1 participant presented with type B tympanograms and 3 participants 
presented with type C tympanograms and had affirmed history of middle ear pathology (See 
Appendix R Table 5-7).   
 
4.4. Medical record 
In terms of objective two, the medical records of the participants were reviewed to determine 
whether children with a hearing loss had received medical management and the type of 
management received. This was achieved through a review of the medical treatment that the 
children had received for HIV and was conducted using a form developed for the study.  
Medical record reviews were compared to the case history and audiological findings. Table 
4.10 reports on the medical record findings related to audiological and ear related 









Table 4.10.  
Medical records indicating hearing related management received 
Records Response 
(N=30) Yes % No % 
Audiological testing received 6 20 24 80% 
Ear related management received 9 30 21 70% 
Audiological intervention received 3 10 27 90% 
 
Six (20%) participants had records of audiological assessments reflected in their ARV clinic 
file and/ or hospital file. Ten (33%) participants had to be referred for wax management 
which included syringing. One (3%) participant had an audiological screening conducted and 
the participant passed the screener as an infant. 
In terms of objective three, reporting on the audiological intervention reported and 
documented, the results revieled that: Audiological intervention was received by 3 (10%) 
patients as described in Table 4.10 above. The Audiological intervention included: 
 Diagnostic audiometry was conducted on 6 (20%) participants, where hearing loss 
was identified and patients referred to ENT for medical management. 
 Three (10%) participants with hearing loss were fitted with hearing aids. 
Nine (30%) participants received medical management that was ear related. The 
management included the following: 
 Issuing of sofradex for ceruman management. 






4.5. Scholastic performance 
Figure 4.7. describes reported scholastic performance. 
 
Figure 4.7: Scholastic performance 
Scholastic history was obtained from the participants in relation to history of repeating 
grades. Fourteen (46%) participants were reported to have repeated a grade while 16 (54%) 
had not repeated a grade, which equates to half of the sample. Fifteen (50%) participants 
reported not coping academically while the remaining 15 (50%) participants reported to be 
coping academically. Cross tabulation was carried out between academic successes and 
hearing loss degree, coping academically and degree of hearing loss and repeating a grade 
and degree of hearing loss. Spearman’s correlation between coping academically and degree 
of hearing loss resulted in a significant value of 0.044.  Cross tabulation analysis was used to 
also find if a relationship existed between reported academic performance and hearing. A p-









































there is no correlation between repeating a grade and hearing status as described. The results 
suggested that the presence of a hearing loss does affect learning and academic progress 
 
4.6. Recommendations based on audiological findings 
Of the 30 participants that had undergone audiological evaluation  07 (23%) participants were 
referred for ceruman management, while 10 (33%) participants were referred to the ENT 
specialist for further management. Two (7%) participants were referred for hearing aid 
evaluation and fittings. Finally, 1 (3%) participant was referred for Speech Therapy, 1 (3%) 




Objective one of the study was to profile hearing using different audiological procedures. 
Abnormal otoscopic findings were observed in 18 (60%) of the participants, which was the 
majority which included ear canal abnormalities such as stenosis, perforated tympanic 
membranes, discharge and wax, which had an impact on the immittance results. 
Immittance results indicated the right ear of 13 (43%) and the left ear of 18 (60%) 
participants  presented with abnormal tympanograms i.e. type B, C and Ad tympanograms.  
The right ear of five participants (17%) and left ear of 6 (20%) participants could not be 
tested due to outer and middle ear pathology. Ipsilateral acoustic reflex thresholds were 
normal in the right ear of 17 (57%) participants   and the left ear of 18 (60%) participants. 
Contra lateral reflex thresholds were normal in the right ear of 12 (40%) participants and the 
left ear of 13 (43%) participants. 
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Of the 28 participants assessed, 16 (57%) participants presented with a hearing loss. 
Conductive hearing loss was the most prevalent type of hearing loss, followed by 
sensorineural hearing loss and mixed hearing loss. The Pearson’s correlation coefficient value 
of 0.01 for the two tailed test was obtained indicating significant correlation between hearing 
loss type, hearing loss degree with viral load and CD4+ T-Lymphocyte classifications. Good 
SRT-PTA correlation was obtained for the majority of the participants, indicating good test 
reliability.  Twenty seven (96%) participants presented with excellent speech discrimination 
ability i.e. scores of between 90-100%. Roll over was not evident in any of the participants. 
Fifteen (50%) participants obtained pass DPOAE in the right ear, while 12 (40%) participants 
obtained pass DPOE in the left ear .The Spearman correlation coefficient revealed a  
significant correlation (p= 0.037) value indicating a correlation between CD4+T-Lymphocyte 
classification, viral load and DPOAE results bilaterally. 
ABR results revealed hearing loss associated with the lower brain stem in the right ear of 3 
(10%) participants and the left ear of 4 (13%) participants. Auditory deficits associated with 
the higher brain stem were evident in the right ear of 3 (10%) participants and the left ear of 3 
(10%) participants. 
Objectives two and three of the study was to report on the medical and audiological 
management received and the nature of management received by the participants for their 
hearing related impairments. Seventeen (43%) participants had a history of ear infections and 
15 (50%) participants reported a receiving medical attention for ear infections which included 
a course of antibiotics, and ear drops.  Audiological intervention was received by 3 (10%) 
participants, where intervention included diagnostic audiometry and referral to and ENT 
specialist for medical management. Three (10%) participants were fitted with hearing aids. 
Ten (34%) participants had to be referred for wax management.  Finally participants were 
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referred to an ENT specialist, Speech Therapist, Educational psychologist and for ceruman 




















CHAPTER 5: DISCUSSION 
5.1. Introduction 
The study aimed to describe the audiological profile of school-age children with HIV/AIDS 
at an antiretroviral clinic in KwaZulu-Natal. The results from the previous chapter will now 
be discussed in relation to the objectives of the study and explained with reference to the 
relevant literature. 
 
5.2. Audiological profiling   
Otoscopic examination, immittance audiometry, pure tone audiometry, OAE and neurological 
ABR tests were used to collect data i.e. to determine hearing status and the prevalence of 
hearing loss. A test battery approach was used as a cross check principle to determine test 
reliability, as recommended by Dworsack-Dodge et al. (2012).  
 
5.2.1. Prevalence of hearing loss in children with HIV/AIDS  
Results of the current study revealed that 15 (57%) participants presented with a hearing loss 
in the right ear and 13 (46%) participants presented with a hearing loss in the left ear as 
indicated by Figure 4.2. Seventeen of the participant’s caregivers (56%) reported that the 
child could hear normally from the case history questionnaire. Therefore, it can be assumed 
that hearing loss in the four participants may have remained undiagnosed, had they not 
participated in the study or until the communication problem became evident. The current 
study finding are higher then the reported prevalance of 20% - 44% reported by Matas et al. 
(2010). Matas et al. (2006) findings reported that hearing loss prevalence in HIV positive 
children ranged between 32% - 42% for the age ranges 3-10 years. Matas et al. (2006) 
established that as a result of compromised immunity, children with HIV/AIDS are prone to 
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hearing loss. Matas et al. (2010)’s study was conducted in Brazil, a developing country with 
an economical status similar to that of South Africa (WHO, 2008).  Therefore, it is evident 
that South Africa has a higher prevalence of hearing loss in HIV infected children than Brazil 
but it appears that audiological profile appears to be similar.  
 
In the South African context, two studies focusing on audiological profiling were conducted 
i.e. Khoza and Ross (2002) and de Lange (2007); however, the target population were HIV 
positive adults. Khoza and Ross (2002) reported the prevalence of hearing loss was  
estimated at 23%, while de Lange’s (2007) reported a  hearing loss prevalence of 55% 
according to the 4 clinical stages of HIV/AIDS. In Khoza and Ross (2002) the prevalence of 
hearing loss appears to be lower than the current study but de Lange (2007) prevalence 
appears to be higher than the current study. This suggests that the prevalence of hearing loss 
has increased over the years possible due to an increased awareness of hearing impairment or 
early presentation of otologic symptoms.  
 
Children are prone to hearing impairment due to high vulnerability to middle ear pathology as 
a direct  result of the immature immune (Abrams et al., 2006) in addition, this compromised 
immunity has been directly linked to the increased susceptibility to infections and is related to 
the acute progression of the disease according to Hugdson and Montgomery (1994). One can 
conclude that the prevalence of hearing loss will therefore be higher in children than adults 
due to vulnerability of the immune system (Mueller & Pizzo, 1997) and  that children are at a 





5.2.2. Prevalence of hearing loss in terms of type, degree, configuration and symmetry of 
hearing loss 
The current study used standard terms to describe the nature of the hearing loss (Gelfand, 
2001) inclusive of terms like conductive, sensorineural and mixed hearing loss. The results of 
the current study, as indicated on figure 4.2., section 4.2.3.2 reveal that conductive hearing 
loss with 26% was the predominant cause of hearing loss in HIV infected school age 
children. Seventeen (57%) participants had a history of recurrent ear infections. The current 
study’s high prevalence of conductive hearing loss echo similar sentiments as  Shapiro and 
Noveli (1998) study, where 44% of participants presented with middle ear pathology.  The 
current study findings are similar to Palacios et al. (2008) who reported that 33% of children 
who were immune compromised presented with a hearing loss as a result of middle ear 
pathology. 
 
On the other hand, the results of the current study are contrary to Weber et al. (2006) and 
Principi (1991) with regards to immunological status and the prevalence of middle ear 
pathology.  Weber, et al. (2006) reported a significantly lower prevalence of middle ear 
pathology i.e. 14.2%, associated with higher CD4+T-lymphocyte count (p= 0.02), while the 
current study found no significant association between CD4+T-lymphocyte count (p=0.48) 
and middle ear pathology.  The Weber et al. (2006) study population age range was from zero 
to 12.11 years using retrospective medical charts review methodology. The difference in the 
sample size and age range can affect the prevalence, resulting in different outcomes.  In 
addition, the sample consisted of 459 children, which is significantly larger as compared to 
the current study. This suggests that CD4+T-lymphocyte count alone cannot be used as a 
measure to indicate susceptibility to middle ear pathology and vulnerability to hearing loss in 




The researcher speculated that the high prevalence of conductive hearing loss could be 
related to the time of data collection. Data collection was conducted during the month of 
June, which in South Africa is winter, a season associated with a higher prevalence of upper 
respiratory tract infections (URTI). This correlated to the reported incidence of upper URTI 
(23%) in section 4.2.2.11. URTI are common risk factors associated with middle ear 
pathology (Cole & Flexer, 2007), and in this study 25 (83%) of the participants reported a 
history of recurrent URT infections increasing their predisposition to middle ear pathology. 
However, in the current study only  eight (27%) presented with symptoms of URTI during 
the audiological testing and of the five (17%) presented with abnormal tympanograms 
supporting the presence of middle ear pathology.  Principi et al. (1991) alluded that the 
pathogens responsible for middle ear pathology are the same in HIV positive children and 
negative children; however  “HIV infection does not favour occurrence of AOM per se but 
predisposes to recurrence” (Principi et al., 1991 p.570).  In addition, Lasis (2005) indicated 
that the cause of middle ear pathology in HIV positive children can be attributed to 
Eustachian tube dysfunction and reduced immunity function which increases the risk to 
middle ear infections (Lasis, 2005). Principi et al. (1991) and Miziara, et al. (2007), highlight 
that immunological status was linked to susceptibility to recurrent episodes of middle ear 
pathology. This current study finding  as related to association between susceptibility to 
middle pathology and tympanometry supports Miziara et al. (2006), who reported that HIV 
positive children tend to suffer more frequent and severe episodes of otitis media as 
compared to immunocompetant counter parts (Miziara, 2007). In the current study, this was 
supported by caregiver reports, where 15 participants (50%) reported a history of ear 




 Further investigations are required to report on the type of middle ear pathology, protraction 
of the infection and pathogen type that are common to the South African context.  Inevitably, 
conductive hearing loss can result from common pathologies such as otitis media, mastoditis, 
tympanic membrane perforation, and recurrent otitis with effusion which can be assessed 
using otoscopy and immittance audiometry (Abrams et al., 2006).  
  
Otoscopic examination revealed abnormal results in 60% of the participants as reflected in 
Table 4.1., Section 4.2.1. The findings of the current study were also similar to the de Lange 
(2007) findings, where she reported dull tympanic membranes, retracted tympanic 
membranes and perforated tympanic membranes as well as in the Gold and Tami (1998) who 
reported that otologic conditions associated with HIV/AIDS include excessive wax, otitis 
media, otitis externa and perforated tympanic membranes. The abnormal ear canal and 
tympanic membrane abnormalities were indicative and suggestive of conductive hearing loss 
which was also confirmed by immittance audiometry. Firstly immittance audiometry could 
not be conducted in the right ear of 5 (17%) participants and the left ear of 6 (20%) 
participants as there was discharge or perforated tympanic membranes. Type B 
tympanograms and type C tympanograms were observed due to abnormalities of the outer ear 
and tympanic membrane.   
 
These findings also correlate with the pure tone audiometry results where conductive hearing 
loss was seen in the right ear of 7 (26%) participants and the left ear of 8 (28%) participants 
as seen in Figure 4.1. in Section 4.2.1.  The findings of the speech discrimination testing of 
the current study are consistent with majority of the participants presenting with conductive 
hearing loss as most participants, as indicated in Table 4.5 in Section 4.2.4.1. presented with 
excellent speech discrimination. Scores of 90 to 100% are usually seen in conductive hearing 
94 
 
loss as a patient with a conductive hearing loss does not experience distortion of speech 
sounds and mainly needs speech to be at a higher intensity to hear accurately (Bluestone, 
Stephenson & Martin, 1992). 
 
OAE may be absent in fluid filled ears and is indicative of possible middle ear pathology, 
resulting in a fail result (Lehmann et al., 2008). In the current study, DPOAEs were 
conducted on the right ear of 18 (60%) participants and the left ear of 17 (56%) participants  
due to the presence of outer and middle ear pathology. In addition, 3 (10%) participants 
presented with a refer results for  DPOAE on the right ear and 5 (17%) participants presented 
with a refer results for left ear. According to Marshall et al., (1997), OAEs are very 
susceptible to middle ear variation, since the negative pressure affects the delivery of the 
stimulus through the, middle ear to the cochlea. Great caution and vigilance is required when 
analysing the results to ensure that absent OAE are not mistaken for outer hair cell damage as 
opposed to the presence of middle ear pathology (Marshal et al.,1997).  
 
In the current study, delays in the absolute latency of waves I, III and V and normal interpeak 
I-III, I-V and III-V were reported  reported on in Table 4.8., on Section 4.2.6.1.  Delayed 
absolute latencies of wave I, III, and V were reported these results suggest possible middle 
ear pathology, this could not be confirmed as audiological ABR was not conducted on the 
participants. 
 
Khoza and Ross (2002) found that CHL was not the predominant cause of hearing loss in 
adults, but sensorineural hearing loss. Sensorial neural hearing loss could result from damage 
to the cochlea (sensory component) and/ or auditory nerve (neural component) (Copley & 
Frederichs, 2010). Viral or bacterial infections such as Cryptococcus meningitis, 
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toxoplasmosis, meningitis, cytomegalovirus, and herpes can result in a sensorineural hearing 
loss (Carney & Muller, 1998). Central nervous system neoplasm and ototoxicity have also 
been reported in children infected with HIV/AIDS. In the current study, only the right ear of 
6 (21%) participants and the left of 1 (4%) participants presented with a SNHL, which was 
dominantly cochlea in origin. However, ototoxic medication results in SNHL (Matas et al., 
2006). This requires further investigation as 21(70%) participants of the current study’s 
participants were on ARV regimen two for a period greater than 2 years and ototoxicity has 
not been established. In addition Maziaria et al. (2006) reported that the prevalence of SNHL 
was as a result of ototoxicity associated with ARV use. Gurney and Murr (2003) highlighted 
that ARVs are ototoxic and result in an irreversible sensorineural hearing loss (Simdon et al., 
2003). It is important to note that these are the same medication reportedly being used by the 
study participants.   
 
To differentiate sensorineural hearing loss in terms of cochlea or neural loss, OAEs have 
been proven to be the most sensitive measure to detect early hearing loss as they measure the 
outer hair cell function of the cochlear (Kramer, 2008). OAEs are predicted to be the by-
product of the neural mechanism of the cochlea amplifier and in particular can be linked to 
the normal functioning of the outer hair cells; thereby making them sensitive to hearing loss 
caused by outer hair cell damage (Koivunen et al., 2000). In the current study, the absent 
DPOAEs could also be attributed to damage to the OHC. 
 
Literature suggests that the HIV virus does not only attack the immune system but there are 
reports of neurological changes which are  subtle  and can only be detected with the use of 
electrophysiological tests measures such as ABR (Matas et al., 2010). Neurological ABR was 
conducted in the current research to assess neural integrity using the Buchaman and Hall, 
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(1998) recommended parameter protocol. The ABR protocol used in the current study, where 
the stimulus rate and intensity, was similar to Paken (2007) study, reached similar findings, 
that ABR is a sensitive tool to identify subtle neurological changes in HIV infected 
population. In addition, faster stimulus rate of testing should be included in the diagnostic 
testing with ABR in HIV positive people (Paken, 2007). However, Paken (2007) cautioned 
that factors such as age, gender should be considered by the clinician conducting the testing 
as it will impact on the results obtained. 
 
Therefore, the current study findings support the finding that ABR is sensitive to detect 
neurological subtleties in HIV positive children, which reinforces the importance of the test 
for neurological monitoring as a result of the virus affecting the neural pathway of hearing 
(Matas et al., 2010). In the current study, it was observed that 2 (6%) participants who 
presented with seizures and the 1 (3%) participants who presented with HIV enchaphalopathy 
presented with abnormal neurological  ABR results. This seems to confirm the reporting by 
Matkin et al., (1998), Bankaitis (1998) and Govender et al., (2011) who indicated that 
HIV/AIDS also affects the neural and central pathways. 
 
 In addition, neurological abnormalities can also be associated with the hearing related 
problems, with reports of auditory processing deficits, central hearing loss and auditory 
brainstem disorders which can negatively affect language development and communication 
(Makar et al., 2012). Neurological complications can manifest in young children through 
failure to attain developmental milestones with the most prominent milestone being language 
delay and cognitive impairment. These manifestations have been associated with cranial 
neuropathy, progressive encephalopathy, microcephaly, meningitis and neoplasm, and are 
reported to occur between the age of 6 months and 5 years, which is during the language 
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acquisition phase (Matkin et al., 1998). Language acquisition, on the other hand, can be 
negatively affected by a hearing loss.  
 
The degree of hearing loss was established through the use of the PTA average for 500Hz, 
1000Hz and 2000Hz frequencies, as recommended by Hogdson (1980), as cited in Northern 
and Downs (2002). As indicated in Figure 4.1 in Section 4.2.3.1, the degree of hearing loss 
varied across the participants, with 8 (26%) participants  presenting with mild hearing loss, 
while 5 (17%) participants presented with moderate hearing loss, 1(4%) participant  
presented with a moderately severe hearing and 1 (4%) participant presented with severe 
hearing loss. This highlights the increased need for audiological monitoring for immuno 
compromised children especially as immune suppression progresses along the HIV/AIDS 
stage classification by CD4 cell count.  
 
 The results of the current study are in keeping with that of Khoza and Ross (2002), where 
mild hearing loss was the predominant degree of hearing impairment in the adult population 
with HIV/AIDS. Similar findings were also reported by de Lange (2007), where 15% of the 
participants presented with a mild hearing loss. A mild hearing loss is usually not detected 
easily even though Speech Discrimination scores of 90 to 100% being obtained by 27 (96%) 
participants  bilaterally evident in Table 4.6 on Section 4.2.4.2.  These scores are a reflection 
of how well the participant understands speech at comfortable listening levels using the 
phonetically balanced (PB) words (Northern & Down, 2002) in an ideal listening 
environment i.e. with no competing sounds. However, school is not an ideal listening 
environment and therefore, Paluski and Kaderavek (2002) reported that children with mild 




Difficulty with listening in the classroom can result in poor academic performance (Most & 
Tsach, 2010).  The findings of the current study revealed similar findings with caregivers 
reporting the participants to present with scholastic difficulties, as indicated in Figure 4.7 in 
Section 4.5.  The impact of hearing loss in the classroom situation includes difficulty hearing 
the teacher’s speech due to background noise and the distance between the teacher and the 
student (Palulski & Kaderavek, 2002). These findings were reported in children without HIV; 
therefore the same will apply to children with HIV, which indicates that even children with a 
mild degree hearing loss require audiological intervention. Case history therefore, in 
audiology is an integral part of a complete test battery as it provides essential information 
related to hearing from the perspective of the family (Gelfand, 2001) as was in the case of the 
current study. 
 
The right ear of twenty three (86%) participants and the left ear of 25 (89%) participants 
presented with good SRT/PTA correlation, while 2 (7%) participants presented with fair 
SRT/PTA correlation in the right ear and 3 (11%) participants presented with poor SRT/PTA 
correlation in both ears.  SRT results are an indicator of speech perception at soft intensities 
indicative of communication difficulties in children with a hearing loss. In addition, children 
with hearing loss had poor early academic difficulties and higher rates of grade repetition due 
to language impairment (Wake & Poulakis, 2004), which this study’s results allude to with  
possible learning difficulties associated with HIV/AIDS as a result of hearing loss. The fair 
and poor correlation could be attributed to poor listening skills and possible central auditory 
processing deficits (Ramkissoon, 2004). 
 
 Early onset of any hearing loss could result in reduced processing at the lower brainstem and 
cortical levels in subsequent years. This suggests that early onset of a hearing loss may lead 
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to auditory processing difficulties (Maruthy & Mannarukrishnaiah, 2008). Auditory 
processing deficits may manifest as poor concentration, poor auditory recall, poor auditory 
analysis and synthesis. The afore-mentioned aspects are essential in reading and writing 
abilities (Feagans et al., 1994).  Hence, deficits in one or more of these aspects may adversely 
affect reading and writing (Most & Tsach, 2010).  
 
A structured case history interview was carried out to obtain pertinent case history 
information.  Six (20%) participants reported delayed gross motor development and 14 (46%) 
participants reported delayed speech language acquisition and development. Hearing loss can 
negatively impact on the different components of language such as syntax, semantics and 
other basic verbal skills (Feagans et al., 1994). From this study, one cannot draw the 
conclusion that the children with a hearing loss present with poor linguistic based pragmatic 
skills resulting in limited opportunities to use language appropriately in a social context 
(Olyer et al., 1998) as the case history questionnaire did not probe further. However, the 
results affirm the hypothesis that children with HIV/AIDS are prone to language delays that 
can make them susceptible to learning difficulties that can affect grade progression. 
 
From the study, 14 (47%) participants reported that the child participant had repeated a grade 
indicating that possible hearing loss has not only affected language development but also 
scholastic performance. Cross tabulation results indicated those who repeated a grade 
presented with mild-severe hearing loss. The participants, who reported that they were not 
coping academically also presented with mild-severe hearing loss. This means children who 
are immunocompromised are also susceptible to learning difficulties associated with hearing 
loss as their HIV negative peers. Palulski and Kaderavek (2002) reported that children with a 
hearing loss will present with communication difficulties, resulting in poor scholastic 
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performance.  Hence it is critical for audiologist to be proactive in the early identification of 
hearing hearing loss to minimise the negative impact on academic progress. 
 
The difficulty with academic progress can be linked to delayed language acquisition, as 
Feagan et al. (1994) stated that language is critical for thinking and learning.  The results of 
the current study suggest that early language development and scholastic performance are 
related and early intervention is crucial in early management of hearing loss and scholastic 
performance. Case history reporting is crucial as part of early hearing detection and 
management (Niskar et al., 1998). 
 
Children with HIV are prone to illness due to their compromised immunity and high 
susceptibility to opportunistic infections resulting in a weaker immune system. In addition, 
ARVs are also reported to cause fatigue as side effects and drowsiness result in less than 
optimal concentration for learning (Giaquinto et al., 2008). Thus the degree of hearing loss 
coupled with weak immunity and vulnerability to illness will negatively affect scholastic 
performance resulting in decline in academic performance and progress. This was highlighted   
by the caregiver’s reports on poor scholastic performance; thus making caregiver reports 
crucial in the holistic care and management of hearing in HIV positive children.  
 
Similarly to the degree of hearing loss and speech discrimination scores impacting on 
academic performance, so too will the configuration of a hearing loss influence the child’s 
performance. A child with a rising hearing loss will miss out low frequency sounds while a 
child with a sloping hearing loss will miss out on high frequency sounds in speech (Sabo, 
2013).  The findings of the current study, as indicated in Figure 4.3 in Section 4.2.3.3. 
revealed the majority of the participants presented with a hearing loss of a rising 
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configuration. Therefore, the finding of the current study were different to that of de Lange 
(2007) findings, who reported a flat configuration to be the most common followed by 
sloping, and then irregular configurations. These findings suggest that hearing loss 
configuration is dependent upon the aetiology of hearing loss (Paluski & Kaderavek, 2002) 
i.e. conductive and rising configuration, where low frequencies are affected and high 
frequencies are better. Hearing impairment, language impairment and scholastic performance 
in children has been directly correlated, and hearing loss symmetry is suggestive of the 
aetiology of hearing loss (Khoza & Ross, 2002). 
 
The findings of the current study revealed that 6 (50%) participants presented with 
symmetrical hearing loss, as indicated in Table 4.4 in Section 4.2.3.4 and 12 (75%) 
participants with a bilateral hearing loss. The findings of the current study is, therefore, in 
keeping with that of Khoza and Ross (2002) where bilateral hearing loss was seen in majority 
of the participants i.e. 71% in Khoza and Ross (2002). Children with hearing loss, 
irrespective of it being unilateral or bilateral will have communication difficulties such 
auditory discrimination in the classroom (Palulski & Kaderavek, 2002); hence, the high 
prevalence of grade repetition due to difficulties in scholastic achievements, as indicated in 
figure 4.7 on section 4.5. Children with unilateral hearing loss were at a higher risk for 
repeating a grade as compared to the children who can hear normally (Most & Tasch, 2010). 
Therefore, unilateral or bilateral hearing loss in HIV positive children will require early 
identification and management. Early identification can be achieved through a test battery 
approach of hearing inclusive of otoscopic examination, immittance audiometry, pure tone 
audiometry, OAE and ABR (electrophysiological measures) which form part of a holistic test 
battery. Therefore, a complete test battery of both behavioural and electrophysiological tests 
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as well as a detailed case history is mandatory when dealing with HIV positive children 
(Beigh et al., 2012).  
 
 5.3 Medical record and audiological management received by children with HIV/AIDS 
on ARV  
Retrospective medical record examinations were carried out by the researcher to ascertain 
medical and audiological intervention received by the participants related to hearing loss. 
Thirteen (43%) participant had other co-existing medical conditions i.e. 11 (36%) participants 
had TB, 1 (3%) participant encephalopathy and 2 (6%) participants had seizures. TB 
management requires the use of ototoxic drugs such as kanamycin, which is ototoxic. In 
addition, TB drugs are known to be ototoxic and yet no audiological monitoring was carried 
out for these participants. This is of great concern as it indicates the lack of ototoxicity 
monitoring, which is part of the scope of practice of an audiologist (ASHA, 2013). 
 
The audiologists’ expertise and their significance in assessment, management and prevention 
of otologic conditions that impair communication including those that result from HIV/AIDS 
have not been clearly understood. As from the case history reports, otologic symptoms 
included pain in the ears, tinnitus, and dizziness. Hearing related conditions are 
underestimated as only 6 (20%) participants were appropriately referred for audiological 
assessments and management. The remaining 24 participants (80%) reported otologic 
conditions but there were no referrals made to the audiologist, suggesting a limited 
understanding of the role and scope of the audiologist as part of the  multidisciplinary team 
that manages children with HIV/AIDS as alluded  to in Chapter 1 Section 1.2. Therefore, in 
the South African context, audiologist have not affirmed their role in the early identification 
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and management of children with compromised immunity. Secondly, though the caregiver 
may report otologic conditions to the medical professional, they may yet not be getting the 
necessary referrals for audiological evaluation. This suggests that the audiologist’s role has 
not been considered and included in the team of people who manage children with HIV.  
 
Only six (20%) participants received audiological management. This included amplification, 
as reported by three (10%) participants, which is in keeping literature trends mentioned in 
Chapter 2. Patients with a hearing loss are fitted with hearing aids, which include bone 
conduction hearing aids, due to recurrent middle ear infections that were not resolving 
(Diefendorf et al., 1990). This suggests that at the research site, audiological practices 
followed literature trends as indicated in Chapter 2 Section 2.10. 
Therefore, the audiologist’s role in the management of the peripheral and central pathology 
that affects communication needs to be included as part of the multi disciplinary team (MDT) 
team as the prevalence of hearing loss in children has indicated the need for early 
audiological intervention. In addition the results have highlighted the role of the audiologist 
in service delivery to the population with HIV, which is in line with “Improving the Quality 
of Health Service” as part of the Government’s Medium Term Strategic Framework (MTSF) 
for 2009-2015.  
 
5.4. Summary 
A hearing loss prevalence based on the pure tone audiometry results revealed  15 (54%) on 
the right ear and the left of 13 (47%) presented with a hearing loss for a sample of 28 school 
age children with HIV/AIDS attending an ARV clinic in South Africa. These findings were 
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similar to Brazil, which is a developing country like South Africa, but South Africa has a 
higher prevalence of HIV/AIDS. In the paediatric population, conductive hearing loss was the 
most predominant type of hearing loss, where mild hearing loss was the most common degree 
of hearing loss and 12 (75%) participants with presented with bilateral hearing loss. The high 
prevalence of mild conductive hearing loss has been established to lead to auditory 
processing deficits that present as reading and writing difficulties, which result in poor 
scholastic performance and grade repetition. 
 
Reported audiological and medical management included a standard hearing test battery to 
establish degree of hearing loss. Participants were fitted with hearing aids as standard practice 
of audiology. Medical management included prescription of medication. The alarming fact is 
that even with a reported history of hearing loss, 80% never had a hearing test conducted, 
indicating that audiological monitoring was not conducted. This implies that the audiologist 
needs to be more proactive in the screening of hearing loss, as this population (HIV positive) 
is prone to hearing loss. Finally audiologist, need to play a proactive role in the early 
identification and monitory of hearing loss with children diagnosed with HIV/AIDS as they 
are susceptible to otologic conditions that will result in hearing loss and this will, in turn, 








CHAPTER 6: CONCLUSION 
6.1. Introduction 
This chapter provides a summary of the main findings, and highlights clinical and research 
implications of the study. In addition, limitations of the study and suggestions for future 
research are provided. 
6.2. Summary of the main findings 
Sub-Saharan Africa is the region with highest number of children under 13 years of age 
living with HIV/AIDS (UNICEF, 2012).  It is estimated by UNICEF (2012) that the number 
of children infected with HIV is approximately 360 000 in South Africa. One of the side 
effects associated with HIV/AIDS are otologic conditions that can result in hearing loss 
(Graber et al., 2008) HIV/AIDS doe not only attack the immunity but also the peripheral and 
central auditory pathway (Lasis, 2005). Hence viral load, CD4 cell count and percentage 
measures can be used as indicators for vulnerability to otologic conditions that give rise to 
hearing loss (Bojrab, 1996).  In addition, ARVs have been reported to be ototoxic; thus, 
resulting in a sensorineural hearing loss (Harris et al., 2012). There is literature that reports on 
audiological profile of adults living with but there is a scarcity of data that reports on the 
prevalence of hearing loss in the paediatric population in South Africa (Khoza-Shangase, 
2010). 
Otologic conditions can affect the outer ear, middle ear, inner ear and central nervous system 
as a result of opportunistic infections associated with compromised immunity (Smith et al., 
2006). As a result hearing loss can range from mild to profound and could be conductive, 
mixed or sensorineural in nature and may require medical and audiological intervention 
(Friedman & Noffsinger 1998).  Hearing loss can affect language development, which 
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negatively impacts on scholastic performance and progress (ASHA, 1997). Finally poor 
academic progresses will impact on the vocational opportunities available and financial 
independence (Carney & Muller, 1998). This, therefore, created an impetus to conduct a 
study on the hearing profile of school aged children on antiretroviral treatment. 
The study was conducted at King Edward VIII Tertiary Hospital in KwaZulu-Natal. Thirty 
HIV positive participants aged between 6- 12 years were recruited, where a test battery of 
audiological assessments was carried out to create an audiological profile. A case history 
interview was carried to ascertain developmental history, hearing related history and 
scholastic history.  A summary of the findings is highlighted below with hearing profiling as 
the first objective: 
 Otoscopic findings revealed abnormal results in the right ear of 17 (57%) participants 
and the left ear of 19 (63%) participants indicative of conductive pathology. 
 Abnormal tympanometry results were observed in the right ear, where 2 (6%) were 
type B tympanograms, 5 (17%) were type C tympanograms and 1 (5%) was a type Ad 
tympanogram. The left ear results revealed 3 (10%) type B tympanograms, and 3 
(10%) type C tympanograms. Ipsilateral acoustic reflex thresholds were abnormal in 
the right ear of 8(27%) participants and the left ear of 7 (24%) participants. Contra 
lateral acoustic reflex thresholds were abnormal in the right ear of 13 (44%) 
participants and the left ear of 12 (40%) participants. There is no significant 
association between the CD4+T Lymphocyte measures and tympanometry using the 
Chi-square test. 
 Of the 28 participants assessed, 16 (57%) presented with a hearing loss where the 
degree ranged from mild- severe to moderately severe on the right ear and mild to 
severe on the left ear. Conductive hearing loss was the predominant type of hearing 
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loss. The Independent T-test and the Pearson’s correlation results were contradictory, 
where the Independent T-test indicated no significant association between the CD4+ 
T-Lymphocyte classifications and degree of hearing loss was observed. However, 
Pearson’s correlation coefficient indicated a significant correlation between hearing 
loss type, hearing loss degree with viral load and CD4+ T-Lymphocyte 
classifications. 
 Of the 16 participants with a hearing loss, four (25%) participants presented with a 
unilateral hearing loss, while the majority 12 (75%) presented with a bilateral hearing 
loss, of which  six (50%) participants presented with a symmetrical hearing loss. 
 Good SRT-PTA correlation was obtained in the right ear of 23 participants (82%), 
and in the left ear of 25 (89%) participants indicative of reliable audiological results. 
 Speech Discrimination scores of 90 to 100% were obtained in both the ears of 27 
(96%) of the participants, while scores of less than 50% were obtained bilaterally for 
1 (4%) participant indicating that majority of the participants did not have difficulty 
with speech discrimination in quiet. 
 The DPOAE testing was conducted in the right ear of 18 (60%) participants and the 
left ear of 17 (56%) participants. The remaining participants could not be tested due to 
the presence of outer and middle ear pathology. In addition, the right ear of 15 (50%) 
participants obtained a DPOAE pass and the left ear of 12 participants (40%) obtained 
a DPOAE pass. These findings confirmed that DPOAEs are susptible to middle ear 
status. 
 While the ABR results indicated presence of neural dysfunction and there  was no 




 Seventeen (56%) of the participant’s caregivers reported that the child could hear 
normally. Six (26%) participants reported that they had a hearing test prior to 
participating in the study. Seventeen (57%) participants had a history of ear infections 
and 50% of participants received medical attention for ear infections. Of the 50% of 
participants with a history of ear infections, medical attention included antibiotics 5 
(16%), ear drops from the clinics 1 (3%), hospital medication 4 (13%), and over the 
counter treatment 1(3%) whilst no treatment was sough or received by 1 (3%) 
participant. Thirteen (43%) participants reported pain in the ears with ear infections 
and seven (27%) participants reported tinnitus. Two (7%) participants reported 
dizziness. Twenty five (83%) participants suffered from recurrent chest infections. 
The recurrent chest infections was associated with predisposition to hearing loss due 
to middle ear pathology as there was a significant correlation between tympanometry 
and recurrent chest infections. 
 In addition, 50% of caregivers reported that the child was not coping currently 
academically, while 14 (46%) reported that the participant had repeated a grade due to 
learning difficulties. Therefore, hearing loss has  a direct link to academic progress. 
 
6.3. Limitations of the study 
 The following limitations of the study have been identified: 
 A small sample size of 30 participants could be recruited due to time constraints , 
limited, human resource to recruit and test. Thirty participants  were recruited due to 
the following reasons: 
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o The primary researcher did not have research assistants to conduct data 
collection. Therefore, due to the the limited human resources only 30 
participants could be recruited for the study. 
o The primary researcher was employed full time by the Department of Health  
and had to comply with employment contract regulations, therefore there was 
not enough time to recruit and test the participants. 
o The participants were recruited for the study, due to the long queues and 
procedures to be carried out, they arrived late for the testing. 
o The number of audiological tests conducted were labour intensive and 
required time, hence a maximum of two patients could be assessed  in a day. 
 Furthermore, convenience sampling was used based on the available time for 
recruiting and the accessibility of the participants (McMillan & Schumacher, 
2001). In addition, the clinic population could not be stratified to get a good 
representation of the general public and therefore, results of the study could not be 
generalised to the wider population (Leedy & Omrod, 2008). However, the 
participants were from various areas across Durban; thus providing a spectrum of 
participant, to counter the effects for bias (Maxwell & Satake, 1997).  
 
 The research design: The current study was part of a short dissertation; as a result 
there was a limited time for data collection. In order to compile an audiological 
profile, longitudinal or cross sectional design has been recommended by literature 
(Hulley et al., 2007).  This will allow adequate time to scrutinize variables and 
report accordingly. However, the current study was a descriptive non-




 Audiological assessment material limitations: Currently South Africa is a 
multilingual country with eleven official languages. The field of audiology is 
English proficient, therefore, vernacular assessment tools are lacking.  Ramkisson, 
(2001) indicated the need to provide services that are culturally and linguistically 
relevant as linguistic diversity has an impact on audiology. This has posed a 
challenge with Speech audiometry testing for this study, as currently isiZulu SRT 
wordlists are available but have not been through the rigorous scientific validation 
process. The material was developed based on familiar words in the language. 
However, the isiZulu discrimination word list, by the virtue of the use at the site 
serves as a partial validation process as published validation of the word list is still 
lacking.  
 ABR testing has only been limited to neurological ABR click high frequency. 
Low frequency tone burst and bone conduction ABR could not be done due to 
time constraints. Tone burst and bone conduction ABR are essential for 
distinguishing hearing loss types, and degree, as part of the cross check principle 
to validate pure tone audiometry results (Bachmann & Hall, 1998). In addition, 
the 11.1ms rate was used; however Matas et al. (2010) and Paken (2007) 
recommended a faster rate is more sensitive to detect the subtle neurological 
changes.  
 
6.4. Significance of the study 
The researcher highlighted the following: 
 The research provided a description of the type, degree, configuration and symmetry 
of hearing loss for children with HIV/AIDS at an antiretroviral clinic in KwaZulu-
Natal. This study reported on the medical and audiological management strategies 
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implemented to effectively minimise the negative impact of hearing loss on academic 
performance. The results may contribute to the national HIV/AIDS research body on 
the disease burden’s impact on quality of life (National Department of Health, 2011).  
 The findings of the current study can be aligned to the National Strategy Plan on HIV, 
STI, and TB 2012-2016 (National Department of Health, 2011), and proposes for 
audiologists to be included in the multidisciplinary HIV/AIDS management team. 
Through the incorporation of services offered by audiologists, there will be a positive 
impact on service delivery and the overall quality of life; thereby, increasing the 
chance of these children becoming financially independent adults. 
 
 6.5. Recommendations for future research 
 Audiological profiling to be carried out on a larger sample size across various sites to 
improve generalization. 
 A cross sectional study to profile HIV/AIDS disease stage with hearing status in 
children should be conducted in order to obtain data that will explore the relationship 
between disease stages and hearing further. 
 A study examining the relationship between ARV regimens and ototoxicity should be 
conducted. This study will benchmark ototoxicity monitoring and testing intervals 
required in order to identify hearing loss due to ototoxicity early.  
 A study focusing on the profile of vestibular pathology and impact on balance should 
be conducted since the HIV virus attacks the peripheral and vestibular system in the 
paediatric population. 
 To further investigate the auditory processing abilities as part of the audiological 





6.6. Clinical implications 
 All children who are HIV positive should be part of an ototoxicity monitoring 
program, in order to identify a hearing loss early. A complete test battery inclusive of 
electrophysiological measures should be utilized. 
 Audiological and medical intervention needs to work in a better collaboration to 
improve referral rates and promote early identification of hearing impairment as a 
result of hearing loss. In addition, early audiological intervention will assist with 
early language development and better scholastic out comes. 
 Inclusion of audiologist in the multi-disciplinary team that manages HIV positive 
children for early identification and monitoring of hearing. 
 
6.7 Summary 
To improve quality of life, the right to communication is crucial and hence audiologists need 
to be proactive in the early screening, diagnosis and management of children with HIV. 
Through the incorporation of services offered by audiologists, this will impact positively on 
service delivery and the overall quality of life; thereby increasing the chance of these children 
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  INFORMATION DOCUMENT FOR CAREGIVERS 
An audiological profile of school-age children with HIV/AIDS at an antiretroviral clinic 
in KwaZulu-Natal 
 
Dear Parent/ Caregiver 
 
I, Zandile Peter, under the supervision of Dr. L. Joseph and Ms. J. Paken, am doing research 
in HIV/AIDS and hearing. I intend to investigate the number of cases of children infected 
with HIV/AIDS that present with a hearing loss at this hospital.  
 
The title of the my study is “An audiological profile of school-age children with 
HIV/AIDS at an antiretroviral clinic in KwaZulu-Natal” 
 
There are many factors that could result in different types, and degrees of hearing loss in 
school age children. My study aims to report on the number of children who are receiving 
ARV treatment presenting with hearing difficulties.  
 
Due to the fact that your child meets the requirements of the study (HIV positive), I would 
like to invite your child to participate in the study, if you agree.   
 
If you agree for your child to participate in the study, you will be required to sign this 
document. The procedure I will follow includes: 
 
1. Looking  in the child’s ear with an otoscope. 
2. Placing a soft probe in the child’s ear.  It is not painful and the child will hear a series 
of beeps that they will listen to but do not need to respond.  
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3. Thereafter, headphones will be placed on the child’s head and he/she will hear a series 
of beeping sounds. When they hear the sounds they will have to press a button. 
Thereafter, they will be expected to repeat words at different levels of loudness. This 
will give an indication about their speech perception and ability to tell the difference 
between words. 
4. Auditory Brainstem Response (ABR) will be conducted while the child is asleep or 
sitting quietly. Special cables (electrodes) are placed on the child’s head and these 
cables will not hurt the child. The computer presents sounds and measures if the 
sound was heard while the child is asleep or sitting quietly.   This test will take 
approximately 20minutes to complete. 
None of the above procedures will place your child at any risk of harm as they are commonly 
used procedures with children. 
 
After all the tests have been completed, you will receive feedback on the results in simple 
language (not using technical terms). You are welcome to ask questions. If other difficulties 
or abnormalities are noted, your child will be referred to the appropriate health provider for 
further assessment and management in the hospital. An appointment will be made by the 
researcher prior your departure after the hearing test. 
 
Your participation in the study,  will make it possible for me to obtain further knowledge in 
this field and this will contribute towards improving audiological management of children 
who are HIV positive presenting with hearing difficulties. 
 
 The test is free, since it will be part of your visit to the ARV clinic. You can withdraw from 
the study at any time with no penalties or negative consequences to you or your child. 
 
To maintain confidentiality and anonymity your personal details will not be used in the 
research but you will be allocated a number to identify your child. The results will be 
presented to my supervisors in the same manner.  
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INCWADI YOMINININGWANO YOMZALI 
 An audiological profile of school-age children with HIV/AIDS at an antiretroviral clinic 
in KwaZulu-Natal 
Mzali 
 Mina Zandile Peter, ngaphansi komphathi udikotela Dr. L. Joseph kanye nonkosazana Ms. J. 
Paken, ngenza ucwaningo kwi HIV/AIDS (ugawulana/inculazi) nokuzwa. Ngihlose ukwenza 
ukucwaningo ngesibalo samacala ezingane ezihanqwe isifo se-HIV/AIDS ezinokungezwa 
kulesisibhedlela. 
Isihloko socwaningo sithi “An audiological profile of school age children with HIV/AIDS 
at an antiretroviral clinic in KwaZulu-Natal” noma “Inani elinika sithombe ngokuzwa 
kwabantwana besikole abanegciwane leHIV/AIDS abahamba eklinic yemishwanguzo 
ekwaZulu-Natali” 
 Ziningi izimbangela eziholela ezinhlobeni ezahlukene, emazingeni okungezwa ngokuhlukana 
kweminyaka yazo. Inhloso yocwaningo lwami ukuthi ngithole isibalo sezingane ezihamba 
ikliniki  yemishanguzo (ARV’s) zibe zibonakalisa ubunzima bokuzwa. 
 Uma kungukuthi umntwana wakho uyahlangabezana nokudingekayo kulolucwaningo 
labanegciwane. Ngingathanda ukumema umntwana wakho abambe iqhaza kulolucwaningo, 
uma uvuma. 
 Uma uvuma ukuba untwana wakho abambe iqhaza kulolucwaningo, kuzomele usayine 
lencwadi yemvume. Umntwana wakho uzohlolwa ukuzwa mahala. Inquba engezoyilandela 
ihlanganisa lokhu: 
1. Ukubuka indlebe yengane nge lambu lokubuka indlebe noma i-otoscope. 
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2. Ukubeka i-probe thambile yerabha endlebeni yengane. Ayibuhlungu, ingane 
izozwa umsindo, kodwa asikho isidingo sokuphendula. 
3. Emva kwalokho, ama-headphone azobekwa ekhanda lengane bese ezwa umsindo 
okhala uthi-beep. Uma ewuzwa umsindo kumele acindezele inkinombo. 
Ulindelekile ukuthi aphinde amagama kanye nezinombolo azizwile eshiwo 
emazingeni angafani okuzwa. Kuzosinika ukuqonda ukuthi uzwa inkulumo 
emazingeni angakanani, futhi kusitshele nokuthi ukwazi kanganani ukuhlukanisa 
magama. 
4. Ukuhlolwa okusheshayo okubizwa nge Auditory Brainstem Response (ABR) 
kuzoqhutshwa. Ngizobeka izintambo (electrodes) ekhanda, ngalesikhathi ehleli 
noma elele. Angeke alimale umntwana. Icomputer izokhipha umsindo, okala 
izinga lokuzwa lomntwana. Lokhu kuhlolwa kuzothatha imizuzu engamashumi 
amabili(20minutes) kuphela. 
Lokukuhlwolwa akubangi ngozi noma akuzumlimaza untwana wakho, ngoba kujwayelikile 
ukusentshenziswa ebantwaneni. 
Emva kokuhlolwa sekuphelile uzothola imiphumela ngolimi oluzwakalayo. Wamkelekile 
ukubuza imibuzo. Uma kukhona okuxwayekile, uzothunyelwa noma adluliselwe kodokotela, 
athole ukuhlolwa nokunakekelwa okwanele esibhedlela. Usuku lokuphinda abonwe 
luzohlelwa ngaphambi kokuba uhambe, emva kokuhlolwa. 
Ukubamba iqhaza kulolucwaningo, kuzosiza ekutholeni ulwazi, futhi kusize indlela usizo 
olungalethwa kubantwana abangezwa ezindlebeni ngenxa yeHIV/AIDS. 
Ukuhlolwa kumahhala njengoba kuzobe kuyingxenye yoku vakashela kwakho emtholampilo 
wemishanguzo noma-ARV. Ungahoxa noma inini kulolocwaningo, awuzukuhlawula. 
 
Ukuze kungcinakale kuyimfihlo ukuthatha iqhaza kulolucwaningo, uzonikwa inobholo. 
Igama lakho neminingwano yakho izokwaziwa umcwaningi kuphela. Othishela bomcwaningi 
bazokwazi ngenombolo. Imniningwano yakho ngeke yaziwe abanye abantu. 
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Title: An audiological profile of school-age children with HIV/AIDS at an antiretroviral 
clinic in KwaZulu-Natal 
You have been informed of the research study by the researcher at the clinic. Your 
participation in this research is voluntary and you will not be penalised if you decide to 
withdraw from the study at anytime.  
 
Your personal information such as name and hospital numbers will be kept confidential by 
allocating you a number during the study. Your personal information will be seen by myself 
as the researcher. Once the research is completed, your records will be kept in a locked 
cupboard for 5 years thereafter it will be destroyed, giving you confidence that all 
information disclosed will be treated with the highest confidentiality and you will remain 
anonymous. 
 
Your child will undergo a hearing test as part of the study. It is at no cost to you. The testing 
procedure will last approximately one hour to one and a half hour. 
 
If you would like to participate in the study, please sign this document to indicate voluntary 
participation by signing below. 
 
The research study intentions have been explained to me verbally. I understand that my 







You may contact the research office for any further queries on the following details: 
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION  
University of KwaZulu-Natal  
Research Office, Westville Campus  
Govan Mbeki Building  
Private Bag X 54001, Durban, 4000  
KwaZulu-Natal, SOUTH AFRICA  




____________________      __________________ 
Signature of caregiver       Date 
Please tick √ 
Consent Yes No 
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IMVUME YOKUHLANGANYELA UCWANIGO (CONSENT DOCUMENT) 
 
Isihloko: An audiological profile of school-age children with HIV/AIDS at an 
antiretroviral clinic in KwaZulu-Natal 
 
Usuchazeliwe ngocwaningo oluqhubekayo lapha esibhedlela, uchazelwa umcwaningi. 
Ukuvuma ukuthatha iqhaza kulocwaningo akuphoqiwe, uma usufisa ukuhoxa nomangasiphi 
isikhathi akunambandela noma isijezo. Uvumelekile ukuhoxa nomangasiphi isikhathi. 
 
Imininingwano yakho efana negama, inombolo yesibhedlela kanye nenombolo yocingo, 
kuzogcinwa kuyimfihlo. Umncwaningi uzokunika inombolo ukuze imininingwane yakho 
ingaziwa. Uma uthatha iqhaza kulocwaningo kuzoba imfihlo. Uma ucwaningo seluphelile, 
imininigwano izogcinwa ekhabetheni elikhiywayo iminyaka emihlanu. Emva kwalesikhathi, 
imininigwano izobhujiswa ukukunika isiqiniseko sokuthi imininingwano yakho ihlala 
iyimfihlo. 
 
Umntwana wakho uzopopolwa izindlebe mahhala njengengxenye yocwaningo. Akukhokhwa 
lutho. Uxilongo luzothatha isikhathi esingange hora kuya kuhora nengxenye. 
 
Uma ufisa ukuthatha iqhaza ucwaningo, ngicela ugcwalise imininingwane elandelayo 
ukukhombisa ukuthi uzivumele awuphoqwa. 
 
Umncwaningi usengichazele ngomlomo izinhloso zocwaningo. Ngiyaqonda ukuthi 
angiphoqiwe ukuzihlanganisa nocwaningo. 




BIOMEDICAL RESEARCH ETHICS ADMINISTRATION  
University of KwaZulu-Natal  
Research Office, Westville Campus  
Govan Mbeki Building  
Private Bag X 54001, Durban, 4000  
KwaZulu-Natal, SOUTH AFRICA  
Tel: 27 31 2604769 - Fax: 27 31 2604609  
Email: BREC@ukzn.ac.za 
 
____________________      __________________ 
Sayina umzali        Usuku 
Ngicela uthikhe √ 
Ukuvuma Yebo Cha 
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ASSENT FORM FOR CHILDREN 
 
Title: An audiological profile of school-age children with HIV/AIDS at an antiretroviral clinic in 
KwaZulu-Natal 
 
My name is Zandile Peter. I am trying to learn about the number of children who have and hearing 
problems. Because you attended the Philani Family Clinic and you are aged between 6-12 years, if 
you would like, you can be in my study.   
  
If you decide you want to be in my study, you will receive a hearing test. This includes: 
1. Looking into your ears with a light. 
2. I will put a rubber probe in your ear. You will hear a beeping sound, but you do not need to 
respond. 
3. Headphones will be placed on your head and you will hear peep sounds and you will press a 
button to tell me you heard the sound.  
4. While you are sitting quietly, special cables will be put on your head. The computer will 
present sounds, you do not have to answer, but sit quietly.   
The hearing tests will not hurt you, as they are used on other children.  
 
At the end of the test we will know if you can hear. If I find that there is problem, I will send you to a 
specialist that will help you. It is good to have your hearing tested to make sure you can hear the 
sounds around you and the people when they talk to you. 
 
Other people will not know if you are in my study.  I will put things I learn about you together with 
things I learn about other children, so no one can tell what things came from you.  When I tell other 
people about my research, I will not use your name, so no one can tell who I am talking about. 
 
Your parents or guardian have to say it’s OK for you to be in the study. After they decide, you get to 
choose if you want to do it too. If you don’t want to be in the study, no one will be upset with you.  If 
you want to be in the study now and change your mind later, that is OK. You can stop at any time.  
 
You can call me if you have questions about the study or if you decide you don’t want to be in the 
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IMMVUME YEZINGANE (CHILDREN’S ASSENT) 
 
Title: An audiological profile of school-age children with HIV/AIDS at an antiretroviral 
clinic in KwaZulu-Natal 
 
Igama lami nguZandile Peter. Ngifisa ukufunda kabanzi ngenamba yabantwana abenkinga 
nokuzwa. Ngoba uhamba ikliniki  Philini Family, futhi uneminyaka engaphakathi kuka 6- 12 
yeminyaka, bengifisa ungene ibe ingxenye yesifundo sami.  
 
Uma ungathanda ukungena kulesisifundo, izohlolwa izindlebe. Kuzokwenzeka lokhu: 
1. Ngizobuka indlebe yakho ngethoshi. 
2. Ngizofaka i-probe ethambile endlebeni. Uzozwa umsindo othi peep. Awudingi 
ukuphendula. 
3. Ngizobeka amheadphones ekhanda. Uzozwa umsindo okhala uthi peep. 
Uzocindezela ikinobho ukukhombisa ukuthi uzwile umsindo. 
4. Ngizobeka intambo (cables) ekhanda. Umshini uzokhanda umsindo othi beep, 
awudingi ukuphendul, umshini uzobal ubone ukuthi uyezwa kangakanani. 
 
 Ukuhlola izindlebe akunabuhlungu, ngoba kwenziwa ezinganeni eziningi. 
Nasesiqedile, ngizokwazi ukuthi uzwa kangakanani. Uma kunenkinga, ngizokuthumela 
kodokotela abozokusiza. Kuhle ukuhlolwa izindlebe, khona uzokuzwa imisindo okuyo kanye 
nabantu umabekhuluma. 
 
Abanye abantu ngeke bazi ukuthi ungomunye abakulesifundo. Lonke ulwazi engilitholayo 
ngawe kanye nontanga angizukusebenzisa igama lakho, akekho ozokwazi ukuthi 
ubunengxenye. Uma ngixoxela abanye ngalisifundo, angizukusebenzisa igama ngebazi 
ukuthi ngikhuluma ngawe. 
 
Umzali usevumile. Thatha isinqumo sokuthi uthanda ukwenzani. Uma ungathandi, ukungena, 
akekho ozojabha, noma ozothetha. Angizukuphatheka kabi. Futhi uvumelekile ukushintsha 
ingqondo noma kunini, akekho ozothetha noma akushaye. Ungayeka noma inini. 
 
Usho uma unombuzo ngalesifundo noma ungasafuni ukuqhubeka. 
 
Ngizokupha ikhopi yalencwadi. Nasengiqedile ngesifundo, wamukelekile ukuthola ukuthi 
ngitholeni kulesifundo. 
Uma uneminye imubuzo ungathintana nothishela bami kulemininingwano Dr.L. Joseph Tel: 











CASE HISTORY QUESTIONNAIRE 
Patient no: 
1Section 1. Biographical information 
1. Age  
2. Gender  
3. Racial group  
 
Section 2: Hearing history (To be completed with the participant and caregiver) 
Please tick in the correct column 
Question Yes No 
Pregnancy and birth 
4. Was the mother healthy during pregnancy?  
4.1. If no, please explain 
 
5. Was the pregnancy full term?  
5.1.If no, elaborate 
 





7. Were there any complications during delivery? 
7.1.  If yes, please explain 
 
8. Was the baby healthy after birth? 
8.1.  If no, explain (e.g. seizures, jaundice etc) 
  
Development 
9. Was the child sitting, crawling, and walking within the normal age range?  
9.1. If no, please explain 
 
10. Are you concerned about your child’s general development, speech-language 
development or hearing development? 








11.1. If so please describe 
 
Hearing related problems 
12. Do you think he/she can hear normally? 
 
13. Did he/she have surgery conducted on the ears? 
 
a. If so, when 
b. What surgery? 
 
14. Did he/she ever have a hearing test before? 
14.1.If so specify 
 
15. Has your child had ear infections? 
15.1 . If so, how many infections, when did they begin? 
 
 
16. Did he/she receive treatment? 
16.1. How were they treated? 
 
17. Does he/she experience or complain of pain in the ears? 
 
18. Does he/she complain of fullness of the ears? 
 
19. Does he/she suffer from high temperature frequently? 
 
20. Does he/she complain of ringing noise in the ear? 
 
21. Does he/she complain that they cannot hear? 
 
22. Does he/she complain of feeling dizzy? 
 
23. Does he/she suffer from recurrent chest infections? 
23.1. If yes, how often 
  
Educational history 
24. What grade is he/she currently in? 
 
25. Has he/she repeated a grade?  
27.1. If so, why? 
 





CASE HISTORY QUESTIONNAIRE (isiZulu) 
Patient no: 
Section1: Biographical information 
1. Age (Iminyaka)  
2. Gender (Ubulili)  
3. Racial group (Uhlanga)  
 
Section 2: Hearing history (To be completed with the participant and caregiver) 
Please tick in the correct column 
Imibuzo Yebo Cha 
Ukukhulelwa nokubeletha 
4. Umama ebenempilo enhle ngesikhathi ezithwele?  
4.1. Uma impendulo ingu cha, ngicela unabe/uchaze kabanzi 
 
5. Wayezithwele izinyanga ezingu 9?  
5.1. Uma impendulo ingu cha, ngicela unabe/uchaze kabanzi 
 
 
6. Wabeletha kanjani? 
6.1. Wazibelethela 
6.2. Wabeletha ngomthungo 
6.3. Wabelethwa ngokusizwa 
 
7. Zabakhona izinkinga ngesikhathi ubeletha?  
7.1. Uma impendulo ingu yebo, ngicela unabe/uchaze kabanzi 
 
 
8. Emva kokubelethwa, umntwana akazange abenezikinga?  
8.1. Uma impendulo ingu yebo, ngicela unabe/uchaze kabanzi (e.g. ukudlikiza, 





9. Umntwana wahlala, wakhasa, wahamba ngesikhathi esifanele? 






10. Ukhathazekile ngokuhluma kolimi lomntwana, nongendlela ezwangayo na? 





11. Ingabe umtwana kukhona ezinye izifo anazo na (isibonenelo, TB, ukudlikiza)? 
11.1.Uma impendulo ingu yebo, ngicela unabe/uchaze kabanzi? 
 
  
Izinkinga ezihambelana nokuzwa 
12. Ucabanga ukuthi umntwana wakho uzwa kahle? 
 
13. Wake wahlinzwa izindlebe ngaphambili?  




14. Zake zahlolwa izindlebe zakhe ngambili? 




15. Wake waphathwa izindle umntwana bakho?  
15.1. Uma impendulo ingu yebo, zaqala nini ukumhlupha futhi kangaki? 
 
16. Walithola usizo? 
16.1. Walithola kuphi, kanjani? 
 
17. Ingabe wake wakhala ngezindle ezibuhlungu? 
 
18. Wake wabika ukuthi kuzwakala ngathi zigcwele indlebe? 
 
19. Uke uhlushwe ukushisa komzimba? 
 
20. Wake wabika ukuthi kunomsindo okhalayo endlebeni? 
 
21. Wake wabika ukuthi akezwa? 
 





23. Simphatha njalo isifuba? 
 
23.1. Uma impendulu kungu yebo nini? 
 
Imlando ngezemfundo 
24. Ufunda liphi ibanga manje? 
 
 




























MEDICAL RECORD FORM 
Patient no: 
Test conducted (obtained from medical records) 
Name of the test Date of 
the results 
Results 






























5.1  ARV commenced on the_______________________________________________ 
5.2  ARV program and dose 














































   




   






12.2.  wet,  
12.3. dry,  
12.4 .blocking view of TM 
13. Foreign body 




16. Position  
a. retracted,  
b. bulging,  
c. normal 
17. Perforation 
18. Cone of light 
19. Discharge 
20. Fluid 
   
Adapted from: Gelfand, (2001) 
Keys: √ yes- indicates normal  
















 Right     
Left     
 
ACOUSTIC REFLEX THRESHOLDS 
Right Stim 500Hz 1000Hz 2000Hz 4000Hz 
Ipsi     
Contra     
Left stim     
Ipsi     
Contra     
 
Distortion Product Otoacoustic Emissions (DPOAE) 
 
Frequencies DP Right ear Left ear Pass/Fail 
8000Hz     
6000Hz     
4000Hz     
2000Hz     
100Hz     
500Hz     








Immittance audiometry procedure: 
Tympanometry: 
Obtaining Tympanogram procedure:  
 The tympnogram was obtained by inserting a colour coded probe into the ear canal and 
automatic function was used.  
 Presentation of a pure tone sound (known as the probe tone) was carried out (Nozza, et al. 
1994).  
Detection of the tone was via miniature microphone in the probe assembly of sound level 
meter within the ear canal (Koivunen et al., 2000).  
 Air pressure changes in the ear canal resulted in the compliance of the tympanic 
membrane and the mobility measured by the probe (Lehmann et al., 2008). 
 Tympanometry requires an airtight (hermetic) seal between the probe tip and the walls of 
the external ear canal. An airtight seal was confirmed when positive or negative pressure 
in the external ear canal is developed at +200 or – 300 mmH O (daPa) (Brouwer et al., 
2007).  If neither positive nor negative pressure could be created in the external ear canal, 
the probe tip should be replaced and reinserted in an attempt to adequately seal the 
external ear canal (Hall, Adlin, May & Bantwal, 2009).  
 Tympanometry was very quick. The systematic change in external ear canal from +200 to 
-200 or -300 mmHO (daPa), and measurement of the resultant change in middle ear 
compliance, takes only 5 to 10 seconds (Hall et al., 2009).  
 
Acoustic Reflexes 
Procedure for obtaining acoustic reflexes: 
 Ipsilateral acoustic reflexes were obtained by inserting a probe tip into the auditory canal 
and ensuring that a good seal had been obtained. Pressuring of middle ear cavity was 
initiated and the acoustic reflex was obtained across 500Hz, 1000Hz, 2000Hz, and 
4000Hz.  
 Contra lateral reflexes are obtained by placing a TDH 39 headphone/contra lateral phone 
was placed on the test ear and the ear probe was placed on the non-test ear to obtain 
contraleteral reflexes. Pressuring of middle ear cavity was initiated and the acoustic reflex 




Immittance Result interpretation 
Tympanometry  
The Jerger classification system of tympanometry was used (Jerger, 1970 as cited in Gelfand 
2001), with the Tympanograms being described as Type A, Type As, Type Ad, Type C and 
Type B. The normative values specific to the AZ 26 (diagnostic) were used. 
 
Table 1 




Source: Gelfand,  (2001). 
 
Acoustic Reflexes 
The range for normal acoustic reflex thresholds are between 70 to 100 dBHL for ipsilateral 
acoustic reflexes and contralateral acoustic reflex thresholds should range from 85 to 














Measurement GSI Range of normal values 
Ear canal volume 0.2 – 1.00cm3 
Compliance peak 0.2 – 1.8mmho 





Distortion Product Otoacoustic Emissions (DPOAE) procedure and intepretation: 
DPOAEs were ascertained by using the (f2/f1) paradigm. Two stimuli of different intensities 
(65/55dB SPL) with two frequency ratio of 1.2 were used. A response was considered present 



























Pure Tone Audiometry procedure 
 Air conduction procedure (Kramer, 2008):  
o The patient was moved into the patient side of the audiometric booth and instructions were 
given. 
o  The audiologist commenced with testing using a familiarization tone at 30-40dB above 
estimated thresholds. Once a response was obtained then threshold search began in the right 
ear at 1000Hz using the ascending bracketing method to thresholds.  
o High frequencies (2000Hz – 8000Hz) were assessed in the same manner. 
o Confirm the threshold of 1000Hz. 
o Low frequencies (250-500Hz) were tested in the same  manner. 
o The results were recorded on the audiogram. 
o Masking was applied when there is a difference of >40dB between the test ear and non-test: 
ACnon-test ear +15. 
 Bone conduction procedure (Kramer, 2008):  
o The participants were allowed a short break in the booth. 
o  Bone conduction vibrator was then placed on the ear with poorer PTA results and testing 
commenced at 1000Hz using the descending by 10dB and ascending by 5dB method until 
threshold was obtained. 
o High  frequencies (2000Hz-4000Hz) were assessed in the same manner 
o Low frequencies (250-500Hz) were assessed in the same manner. 
o The results were recorded on the audiogram. 
o In the cases where BC was 10 dB or better than air conduction, masking was introduced using 
headphones to raise the threshold in the non-test ear using air-conducted sound and effective 
masking formula, as recommend by Ahmad and Pahor  (2002).  
AC of non test ear + 15 + Occlusion effect 
The following occlusion effect values are described: 
Table 1 
Occlusion Effect values 










Hearing loss classification 
Table 1 
Degree of hearing loss  
Severity range(PTA)  Decibels (dB) 
Normal 0 – 15 dB 
Mild 16 – 40 dB 
Moderate 41 – 55 dB 
Moderately severe 56 – 70dB 
Severe 71 – 90 dB 
Profound >90 dB 
Source: Gelfand, (2001) 
 
Table 2 
Hearing loss type 
Hearing loss type Description  
Conductive The hearing loss is a result of the middle ear being affected. The audiogram results will indicate 
air bone gaps of >10dB across all frequencies. Bone conduction thresholds can be depressed not 
exceeding 25dB levels. 
Sensorineural This hearing loss results from cochlear impairment and the auditory nerve. The audiogram results 
will indicate depressed air conduction and bone conduction thresholds with no air bone gaps.  
Mixed This hearing loss indicates that there is a conductive and sensorineural component. Both air and 
bone conduction thresholds will be depressed with certain frequencies presenting with an air bone 
gap greater than 10dB. 
Gelfand, (2001).  
Table 3 














Flat No more than 5-10dB change per octave 
Sloping Greater hearing loss for high frequencies (15-20dB per octave) 
Ski-slope More than 20dB loss per octave 
Rising Worse in the low frequencies, improving by 10-20dB per octave 
Cookie bite Worse in the low and high frequencies 
Trough Worse in the mid frequencies 




SPEECH AUDIOMETRY PROCEDURE 
 Speech Reception Thresholds (SRT): The participant was instructed to repeat words 
or numbers as they heard them. Then SRT was obtained in the right ear and then the 
left ear. The following procedure was used, as recommended in Kramer (2008).  
o The child was seated on a chair in a sound proof booth at 90 degree 
with headphones on their heads.  
o The audiologist commenced testing at PTA + 40dB L to familiarise the 
child to the word list.  
o The audiologist used the children’s Spondee word list in English and 
the digit test for IsiZulu .  
o The child had to repeat the words as soon as they heard them, using the 
ASHA Method of obtaining SRT. 
 
 Speech Discrimination Results (SD): SD was obtained in the same ear. Then SRT and 
SD were obtained in the left ear.  
o The researcher used 3 presentation levels where the following 
formulae were applied to establish the levels: Level 1-SRT+ 20dB, 
Level 2-SRT +30dB, and Level 3-SRT +40dB (North & Downs, 
2002). 
o A list of 25 words was read and the percentage of words correctly 
identified was obtained through: 
𝑆𝐷 𝑆𝑐𝑜𝑟𝑒 =













Speech audiometry normative data 
Speech Reception Thresholds (SRT) 
Reliability rating  
For each testing session the audiologist rated the reliability of results as “good,” “fair,” or 
“questionable.” Reliability used Pure Tone Average (PTA) and Speech Reception Threshold 
(SRT) correlation. Good correlation will results from 0-5dB, fair correlation 6-10 and poor 
>10dB difference (Ahmad & Pahor, 2002; Northern & Downs, 2002).  
Speech discrimination (SD) 
Table 1 
Word Recognition Scores and interpretation  
Word Recognition Score Percent 
correct 
Degree of impairment Word Recognition ability 
100-90 None Excellent 
89-75 Slight Good 
74-60 Moderate Fair 
59-50  Poor Poor 
<50 Very poor Very poor 
Source: Kramer, (2008).  
 
Table 2 
Interpretation of SDT data 
Hearing loss type Speech results 
Normal hearing  PB Max of 100%   
Conductive hearing loss PB Max of 100% achieved at higher intensity levels 
for  PI-BP function 
Sensorineural (cochlear) May reach PB Max of   100% or a dynamic range of 
<45dB suggest recruitment 
Sensorineural (retrocochlear) Difficulty with attaining PB Max of 100% 
discrimination with roll over >20% 
PI-BP function roll over ratio >0.45 




DIGIT WORD LIST FOR NON-ENGLISH SPEAKERS (Ramkisson, 2000) 
nine-four  eight-five  six-six 
five-one   three-six   eight-ten 
one-ten   four-six   one-four 
six-ten   ten-nine   nine-nine 
four-one   one-one   four-three 
three-one  six-four   ten-ten 
eigth-one  five-two   two-eight 
six-one   two-one   six-five 
one-three  nine-one   three-ten 
eigth-nine  two-six   four-nine 
nine-ten   nine-eight  one-two 
two-four   five-ten   five-three 
ten-four   four-four  three-five 
four-two   three-four  six-three 
one-eight  eigth-eight  two-two 
six-nine   ten-one   five-nine 
three-two  six-eight   nine-two 
two-nine  eight-four  three-three 
ten-five   one-five   nine-six 
five-eight  five-four  two-five 
nine-five  two-three  ten-six 
ten-eight  ten-three  eight-three 
ten-two   nine-three  one-six 
one-nine   two-ten   three-eight 
four-eight  six-two   four-ten 






ISIZULU SPEECH DISCRIMINATION (Balkisson, 2001) 
bheka    bonga 
cela    cula 
dlala    funa 
faka    hlala 
hamba    kama 
luma    nika 
ngena    phinda 
phuza    phuma 
pheka    qala 
shaya    suka 
susa    thinta 
thatha    thula 
vuka    vula 
vala    washa 
gcoba    geza 
ndiza    thanda 
buka    gqoka 
gula    hleka 
jika    khipha 
khala    phatha 
sula    shesha 
fihla    nuka 
gona    ganga 
veza    yeka 





Skin preparation  
The skin at the electrode sites were prepared to ensure that the impedance was low enough for a good 
recording. The skin was scrubbed with abrasive gel at the place of electrode placement (Jassen, 2008). 
 Electrode placement and impedance (Hall, 2007)  
Placement:  
1. Four electrodes were used (one on the high forehead (Fz) one on the forehead (Fpz) and two 
for the earlobes (A1 &A2).  
2. The non-inverting electrode was placed on the high forehead as close as possible to the 
hairline, in the midline. The electrode lead was away from the face.  
3. The inverting electrode was placed on each earlobe area. 
4. The four electrodes were properly placed to provide two differential recording channels: 
forehead to left earlobe and forehead to right earlobe.  
5. The common electrode was placed on the forehead, ≥ 3 cm over from the non-inverting 
electrode (centre to centre). The electrode lead was away from the face.  
6. Electrode wires were kept close together and if possible braided to decrease 60-Hz artefact.  
 
Impedence (Jassen, 2008):  
1. Impedence should be less than 3Kohms 


















Minimum response rate 
Polarity Rarefaction 













Source: Bachmann, & Hall,   (1998).  
Testing protocol 
The following test protocol, as recommend by Bachmann & Hall (1998), was adhered to:  
1. To review the audiological function based on the behavioral audiogram. 
2.  Click ABR protocol 
 Start with a click ABR at 80dBnHL for and verify the presence of waves I, 
III, and V.  
 Repeat to verify the response. 























Appendix N2  
ABR Result interpretation 
 
Response present (Bachmann & Hall, 1998):  
Visual criteria:  
 The response amplitude is at least 3 times the amplitude of the average difference (noise) of 
the waveform within the SNR region 
 
Statistical criteria:  
 The signal to noise ratio (SNR) of the overall average of the waveforms is greater than 1.0  
 The waveforms within the SNR region must be greater than or equal to 0.46  
 
Response absent:  
Visual criteria:  
 Waveform should appear visually quiet, with no apparent replicable waveform  
 
Statistical criteria:  
 Waveform should be below: 0.11 μV for single waveform, and 0.08 μV for combined. 
Auditory brainstem response latency values for click ABR. 
 
Table 1 
Anticipated absolute and interpeak latencies values for click ABR 
Intensity levels Absolute Latencies Anticipated values for 
click ABR 







80dBnHL Interwave latencies Anticipated values 
 I-III 2.28ms 
 III-IV 1.86ms 
 I-IV 4.13ms 





Classification of click ABR results (Matas et al., 2010): 
 Lower Brainstem (LB) will be identified as normal absolute latency of wave I and 
interpeak III-V latency and increased latencies of waves III and V and interpeak I-III 
and I-V.   
 Higher Brainstem (HB) will be identified as normal absolute latencies of waves I and 






































INFECTION CONTROL  
 Patient contact: 
 Appropriately-fitting gloves, either latex or non-latex, were worn during 
all procedures.  New gloves were used for each patient during otoscopic 
examination, immittance, and OAE probe insertion. The hospital was 
provided with gloves as part of the consumables for the department. 
 Protective apparel such as a white coat was worn at all times during 
audiological test procedures. Masks were used when the researcher was in 
contact with patients suspected of TB or any upper respiratory tract 
infection. 
 Hand hygiene strategies such as the use of medical grade liquid 
antibacterial soap was used after contact with each patient. Hand washing 
techniques was followed. 
 
 Environmental hygiene 
 Contact surface cleaning. Touch surfaces could include tables, armrests of 
chairs, service areas, workbenches, or counter tops. Splash surfaces are 
areas that could be hit with blood, bodily fluids, or secretions from a 
patient.  These were done using anti-micro bacterial alcohol based 
sanitizer such as habitane provided by the hospital. 
 Non-critical instruments are those instruments that either do not ordinarily 
touch the patient or touch on the externally intact skin.  All instruments 
used with multiple patients was sterilized.  Instruments such as head 
phones were sterilised using alcohol swabs to wipe them prior and after 
testing each patient.  Otoscope specula, nubs for OAE probes and 
immittance probes were soaked in hebitane and antibacterial soap after 
use. Then the items were rinsed in water and dried with a disposable towel 






























men RE LE RE LE RE LE RE LE RE LE RE LE RE LE RE LE
p1 7 m 943 1 43% 40 1 2 N N C B AB NR AB NR MILCHL MILCHL P P CNT CNT AB AB (HB)
p2 9 m 982 1 19.7 39576 1 2 AB N C C NR NR NR NR MILCHL MILCHL G G CNT CNT AB(LB) AB
p3 11 f 1577 1 38.5 LTD 3 1 N N C A AB N AB AB MILSNHLMILMIXHL G G R P N N
p4 6 m 19 3 0.66 151849 2 1 N N A A N N N N N N G G P R N N
p5 6 m 2237 1 25.7 LTD 3 2 AB AB B CNT NR CNT CNT CNT MILCHL MILCHL G G CNT CNT AB(CHL) AB
p6 8 f 1010 1 30.8 <40 3 2 AB AB B B AB AB AB AB MILSNHLMILMIXHL F G CNT CNT AB AB(LB)
p7 11 m 1125 1 35.2 3 1 N N A A N N N N N N G G P P N N
p8 11 m 1129 1 30.7 250 2 2 AB AB CNT CNT CNT CNT CNT CNT MODCHLMODCHL F G CNT CNT AB(HB) AB
p9 10 m 723 1 24.2 2392 2 2 AB AB CNT CNT CNT CNT CNT CNT MILCHLMODCHL G G CNT CNT AB AB
P10 9 m 872 1 25.2 LTD 3 2 AB AB AD CNT N AB AB AB N MILCHL G G P CNT N N
p11 7 f 1231 1 27.7 LTD 3 2 N AB A A N N N N N N G G P P AB(LB) N
p12 11 m 1718 1 33.8 LTD 3 1 AB AB A A N N N N CNT CNT CNT CNT CNT CNT N AB(LB)
p13 12 f 5312 1 29 LTD 3 2 AB AB A A N N N N N N G G P P N AB(LB)
p14 8 m 382 2 8.7 22416 1 1 N N A C N N AB AB MILSNHL N G G P CNT AB(HB) AB
p15 9 m 1432 1 31.7 LTD 3 2 N N A A N N N N N N G G P P AB N
p16 8 f 1102 1 21.4 2 1 N AB C B NR AB AB NR CNT CNT CNT CNT CNT CNT AB(HB) AB
p17 7 m 120 3 1 980 2 2 AB AB CNT CNT CNT CNT CNT CNT MILCHL MILCHL G G CNT CNT AB(LB) AB
p18 10 m 2 AB AB CNT CNT CNT CNT CNT CNTMOD-SEVCHLSEVMIXHL G G CNT CNT N AB
p19 6 m 1010 1 29.9 1 AB AB C C AB AB AB AB MILCHLMODCHL G G CNT CNT N AB(LB)
p20 9 m 595 1 32.6 LTD 3 1 AB AB A A N N N N MILSNHL N G G P R N N
p21 7 f 702 1 26.6 LTD 3 2 N N A A N N N N N N G G P P N N
p22 9 f 948 1 39.7 2 N AB A A N N N N N N G G P P N AB(HB)
p23 7 m 2094 1 30.3 2494 1 2 AB AB A A N N N N N N G G P P N N
p24 10 m 894 1 26.7 LTD 1 2 AB AB A A NR N NR N N N G G R R N N
p25 12 m 2 N N A A N N NR NR N N G G R R N N
p26 12 f 193 1 17 6882 1 2 AB AB A A N N NR NR MILSNHLMILSNHL P P P P N N
p27 9 f 1046 1 40.5 LTD 3 2 N N A A N N N N MILSNHLMILSNHL P P P P N N
p28 9 f 1699 1 31.5 LTD 3 2 AB AB CNT A CNT NR CNT NR MILMXHL N G G CNT R AB N
p29 9 f 1766 1 46.1 LTD 3 2 AB AB A A N N N N N N G G P P AB AB
p30 10 f 1577 1 44.8 LTD 3 1 n N A A N N NR NR N N G G P P N AB(HB)
Note: N=Normal, AB=Abnormal, NR= No response, CNT= Could not test, G=Good, R= Refer,  AB(HB)=Abnormal higher brainstem, AB(LB)=Abnormal lower brainstem
MOD=Moderate, SEV=Severe, CHL=Conductive hearing loss,MILD=Mild, Sensorineural hearing loss, MIXHL=Mixed hearing loss,
Immunological status
Immittance audiometry
OAE ABRotoscopic Tymps Ipsi contra pure tone speech






Table 1  












1 .079 -.127 
Sig. (2-tailed)  700 .536 






.079 1 .827 
Sig. (2-tailed)  700 .536 
N 26 28 28 




-.127 .827 1 
Sig. (2-tailed) .536 .000  
N 26 28 28 













Table 2.  
Correlation between CD4 cell  categories and hearing loss degree 
  Right PTA 
degree of hearing 
Left PTA degree 
of hearing 







1 .827 -.175 
Sig. (2-tailed)  .000 .392 
N 28 28 26 
Left PTA degree 
of hearing loss 
Pearson’s 
correlation 
.827 1 .100 
Sig. (2-tailed) .000  .626 





-.175 .100 1 
Sig. (2-tailed) .392 .626  
N 26 26 28 
















Table 3.  
Correlation between viral load categories and hearing loss type 










1 .044 -.212 
Sig. (2-tailed)  .831 .299 
N 28 26 26 




.044 1 .706 
Sig. (2-tailed) 831  .000 
N 26 28 28 




-.212 .706 1 
Sig. (2-tailed) .299 .000  

















Table 4.  
Correlation between CD4 cell categories and hearing loss degree 













1 .827 -.175 
Sig. (2-tailed)  .000 .392 






.827 1 .100 
Sig. (2-tailed) .000  .626 





-.175 .100 1 
Sig. (2-tailed) .392 .626  
N 26 26 28 












Table 5  
Correlation between history of recurrent chest infections and middle ear pathology 
  Recurrent chest 
infections Right tymp Left tymp 
Recurrent chest 
infections 
Pearson’s correlation 1 -.144 -.157 
Sig. (2-tailed)  .550 .406 
N 30 30 30 
Right  tymp Pearson’s correlation -.144 1 .748 
Sig. (2-tailed) 550  .000 
N 30 30 30 
Left  tymp Pearson’s correlation -.157 .748 1 
Sig. (2-tailed) .406 .000  
N 30 30 30 
 
Table 6 
Cross tabulation between history of chest infections and right Tympanometric results 
  Right Tympanometric type   
  Type A Type B Type C Could not test Total 
History of chest 
infection 
yes 2 1 3 1 7 
no 14 0 4 5 23 





Table 7.  
Cross tabulation between history of chest infections and left Tympanometric results 
  Left Tympanometric type   
  Type A Type B Type C Could not test Total 
History of chest 
infection 
yes 3 1 1 2 7 
no 15 4 0 4 23 
Total  18 5 7 6 30 
 
 
 
